A mathematical study of CD8+ T cell responses calibrated with human data by Gosling, John Paul et al.
A mathematical study of CD8+ T cell responses calibrated with
human data
John Paul Gosling1, Sheeja M. Krishnan2,3, Grant Lythe2, Benny Chain4, Cameron Mackay5
and Carmen Molina-Par´ıs ∗2
1Department of Statistics, School of Mathematics, University of Leeds, Leeds LS2 9JT, UK
2Department of Applied Mathematics, School of Mathematics, University of Leeds, Leeds LS2
9JT, UK
3Modelling and Economics Unit, National Infection Service, Public Health England, 61
Colindale Avenue, London NW9 5EQ, UK
4Division of Infection and Immunity, UCL, Gower St, London WC1E 6BT, UK
5Unilever Safety and Environmental Assurance Centre, Sharnbrook, MK44 1LQ, UK
20th June 2017 - final version - LATEX
Abstract
Complete understanding of the mechanisms regulating the proliferation and differentiation that takes
place during human immune CD8+ T cell responses is still lacking. Human clinical data is usually limited to
blood cell counts, yet the initiation of these responses occurs in the draining lymph nodes; antigen-specific
effector and memory CD8+ T cells generated in the lymph nodes migrate to those tissues where they are
required. We use approximate Bayesian computation with deterministic mathematical models of CD8+
T cell populations (naive, central memory, effector memory and effector) and yellow fever virus vaccine data
to infer the dynamics of these CD8+ T cell populations in three spatial compartments: draining lymph
nodes, circulation and skin. We have made use of the literature to obtain rates of division and death for
human CD8+ T cell population subsets and thymic export rates. Under the decreasing potential hypothesis
for differentiation during an immune response, we find that, as the number of T cell clonotypes driven
to an immune response increases, there is a reduction in the number of divisions required to differentiate
from a naive to an effector CD8+ T cell, supporting the “division of labour” hypothesis observed in murine
studies. We have also considered the reverse differentiation scenario, the increasing potential hypothesis.
The decreasing potential model is better supported by the yellow fever virus vaccine data.
1 Introduction
In response to cognate antigen, a single naive T cell is able to produce multiple subsets of memory and effector
T cells of different phenotypes and functional properties [1]. Recent studies suggest that, in humans, this
differentiation process follows a linear progression characterised by the following transitions: from naive (N) to
stem cell memory (SCM), to central memory (CM), to transitional memory (TM), to effector memory (EM),
and to (terminal) effector (or EMRA) (E) T cells [2, 3]. Stimulation by cognate antigen seems to drive less-
differentiated cells to generate more-differentiated progeny. Yet, the mechanisms that control the proliferation
and differentiation steps during an immune response, from the activation of naive T cells to the generation of
memory and effector cells, are not clearly understood [4–7].
In the case of CD8+ T cells, a few of these mechanisms have already been identified and have helped decipher
some of the rules that govern CD8+ T cell differentiation (see Ref. [4]). This study showed that, after antigenic
stimulation, naive CD8+ T cells become committed to multiple rounds of division, then differentiate into effector
and memory cells. That is, once the parental naive CD8+ T cell has been activated, a developmental program
is triggered, in which daughter cells continue to divide and differentiate without further antigenic stimulation.
Thus, the initial antigen encounter initiates an instructive developmental programme that leads to effector and
memory CD8+ T cell formation and confers protective immunity [4, 5].
Mathematical models, together with experimental and clinical data, have improved our understanding of
CD8+ T cell responses and the generation of effector and memory cells during infection. For example, Ref. [8]
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combines mathematical modelling with experimental data from clinical studies of yellow fever virus (YFV)
to explore kinetic details of the human immune response to vaccination. Some important results from this
study include: i) the estimation of the doubling time of effector CD8+ T cells to be around two days, ii) that
the peak of the CD8+ T cell-mediated immune response depends on the rate of T cell proliferation, and iii)
that the observed expansion of the YFV-specific CD8+ T cell population was achieved in fewer than nine cell
divisions [8]. The authors made use of a simple mathematical model, based on Refs. [9, 10], to describe the
fraction of YFV-specific CD8+ T cells in the secondary lymphoid organs (SLOs) and circulation (blood). The
model includes migration from SLOs to blood and from blood to tissues, as well as proliferation in the SLOs
(before the peak of the response) and death both in the SLOs and in blood, only after the peak of the response.
They calibrated their mathematical model with the average (among all patients) fraction of specific CD8+
T cells from the YFV vaccine data in Ref. [11] (see Figure 3B in Ref. [11]).
In two other examples of combined experimental and modelling studies, the authors have followed the clonal
expansion of transgenic OT-1 cells in mice. Their experiments identified a heterogeneous population of CD8+
T cells arising from naive cells during bacterial infection, and showed that the clonal expansion and differenti-
ation of individual naive T cells is highly stochastic [12, 13]. These stochastic events, from multiple individual
precursors, gave rise to a robust cellular fate. Mathematical modelling and parameter calibration indicated
that CD8+ T cells follow a linear developmental path, with long-lived slowly-proliferating cells differentiating
to short-lived, highly proliferating cells [12]. Finally, Gong et al. have recently developed a hybrid approach,
that uses an agent-based model in the lymph nodes (LNs) and an ordinary differential equation (ODE) model
in the blood compartment [14]. This multi-compartmental model considers the following events: the interaction
of naive T cells with antigen-bearing dendritic cells (DCs), as well as cellular proliferation and differentiation
in two spatial locations (LNs and blood) [14]. The model was calibrated with mice lymphocytic choriomen-
ingitis virus (LCMV) infection data and the authors concluded that the cellular heterogeneity observed can be
attributed to the number of antigen-bearing DCs that each naive T cell is responding to [14].
A number of questions about the kinetics of CD8+ T cell-mediated immune responses remain unanswered.
For example, the sequence of differentiation steps during a CD8+ T cell response is unknown: is it from naive
to effector to memory or from naive to memory to effector? A related second question is more technical. As
human clinical data is usually limited to blood cell counts, how feasible is it to develop a mathematical model
with spatial compartments, such as the draining lymph nodes, circulation (or blood) and tissues, that can be
parameterised with data from only the blood compartment? Finally, flow cytometry and tetramer staining
allow us to identify and measure, within the blood compartment, the fraction of antigen-specific CD8+ T cells
in the total CD8+ T cell population. It remains a challenge to develop mathematical models of the kinetics
of CD8+ T cell-mediated immune responses that include different CD8+ populations (naive, central memory,
effector memory and effector) in the three previously mentioned spatial compartments, that can be calibrated
with human data.
In this paper, we analyse population-average models of CD8+ T cell dynamics that include four cellular
populations: naive, central memory, effector memory and effector T cells, and three spatial compartments: the
draining lymph nodes, circulation and skin. We note that each CD8+ T cell subpopulation is defined in terms
of its homeostatic ability to proliferate or not, its survival capability, migration pattern, its division rates in
the presence of antigen, as well as the number of divisions required to differentiate (see Section 2.1) [15]. Since
our mathematical models will be calibrated with the fraction of total specific CD8+ T cells from the YFV
vaccine data in Ref. [11] (see Figure 3B in Ref. [11]), our definition of naive, central memory, effector memory
and effector CD8+ T cells is not based on their expression levels of CD45RA and CCR7 as provided by flow
cytometry data [16, 17]. In this sense, our definition of naive, central memory, effector memory and effector
CD8+ T cells is based on cell function instead of phenotype.
In order to decipher the sequence of differentiation events during an immune response, we first consider the
decreasing potential (DP) hypothesis for generating CD8+ T cell heterogeneity [12], with differentiation events
linked to division [18]. We have made use of the literature to obtain rates of division and death for each human
CD8+ T cell population subset, as well as naive T cell thymic export rates. Approximate Bayesian computation
(ABC) has been used together with the mathematical model and YFV vaccine data from Ref. [11] (see Figure 3B
in Ref. [11]) to obtain posterior distributions of the subset of parameters related to the immune response, such
as the number of divisions in the differentiation programme, the time to first division, the time to subsequent
divisions, the number of specific clonotypes involved in the response, the duration of the immune response, and
migration rates. We find that as the number of clonotypes driven to an immune response increases, there is
a reduction in the number of divisions required to differentiate from a naive to an effector CD8+ T cell, thus
supporting the “division of labour” already observed in murine studies [13,19]. We then consider the increasing
potential (IP) hypothesis for generating CD8+ T cell heterogeneity [20], and compare it with the decreasing
potential model. Mathematical modelling, Bayesian computation and the YFV data provide marginally stronger
support for the DP than the IP hypothesis. We have also performed a sensitivity analysis of both models to
determine the extent to which the parameters influence the population dynamics and circulatory kinetics of
CD8+ T cells through the draining LNs, circulation and skin.
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The structure of the paper is as follows: Section 2 provides a brief description of the mathematical models
used to describe CD8+ T cell dynamics (homeostasis, decreasing potential and increasing potential hypotheses),
the choice of model parameters and the computational algorithm. We also describe the sensitivity analysis
carried out, as well as the YFV vaccination data used to calibrate the models. The results of our study are
presented in Section 3, namely model calibration for both DPM and IPM alongside a comparison of the two
models. We discuss our results in Section 4. In Section 5, we provide full details of the mathematical models
(ordinary differential equations for the homeostasis, decreasing potential and increasing potential models). We
also provide an extensive literature review highlighting the sources for our parameter estimates for the number
of cells, carrying capacities, division rates, death rates, thymic export rates, migration rates, times to first and
subsequent divisions, as well as the number of clonotypes recruited to an immune response and the duration
of the immune response. Finally, we describe the methods involved in the sensitivity analysis and Bayesian
calibration of the mathematical models.
2 Materials and methods
2.1 Mathematical models
2.1.1 Mathematical model of T cell homeostasis
A subset of the diverse population of CD8+ T cells generated during an immune response is preserved once
antigen is cleared. This is due to the homeostatic mechanisms that are in place to maintain both the size and
T cell receptor (TCR) diversity of the CD8+ T cell population. Thus, we require a mathematical model of CD8+
T cell homeostasis (in the absence of cognate antigen). Full details of the model are provided in Section 5.1.1
below. We now present a brief summary of the model.
The homeostasis model includes three subsets of CD8+ T cells: naive (N), central memory (CM), and effector
memory (EM) cells. Naive cells are further divided into antigen-specific and non-specific naive T cells. CM and
EM cells are assumed to be specific to a fiducial skin-delivered antigen (or cognate antigen). The naive and
central memory populations reside in the draining LNs (dLNs) and blood compartments. Effector memory cells
can also reside in the skin [21] (see Figure 1).
In what follows we describe, for each cellular subtype, the processes that are included in the homeostasis
model:
• Naive cells are released from the thymus into the circulation, and we assume a constant thymic export
rate per clonotype, denoted by δ. We denote by δr, the total thymic non-specific export rate (see Table 1).
• Division is assumed for N, CM and EM CD8+ T cells to be logistic [22], with proliferation rate, θ and
carrying capacity per clonotype, κ. This logistic term encodes competition for resources, and thus avoids
unlimited exponential growth of the populations. The rates are denoted by the subscripts n, c, and m for
naive, central memory, and effector memory cells, respectively (see Table 1).
• Each subset of CD8+ T cells has a finite lifespan, and we assume that the death rates are independent
of the spatial location. We denote them by µ and make use of the subscripts n, c, and m for naive,
central memory, and effector memory cells, respectively (see Table 1). The death term of each subset is
proportional to its population size.
• Migration for any cell type is assumed to be proportional to its population size. We assume naive and
central memory cells circulate between dLNs and the blood compartment. Effector memory cells migrate
from the dLNs to the blood compartment, and are assumed to circulate between skin and the blood
compartment (see Table 2).
We have assumed that each population maintains its numbers independently [23–25]. Naive cells are released
from the thymus and divide due to TCR interactions with self-peptides expressed on antigen-presenting cells,
or IL-7 cytokine signalling [26]. Effector memory cells maintain their numbers by homeostatic mechanisms
that involve cytokine IL-15, while central memory cells use both IL-7 and IL-15 [5, 27]. We assume that the
death and division rate of each CD8+ T cell subtype is independent of its spatial location. Naive and central
memory cells migrate between dLNs and circulation, while effector memory cells can also migrate to the skin.
The migration rates of naive and central memory cells are assumed to be same [28], as the trafficking molecules
CD62L and CCR7 are expressed on both populations [29]. Effector memory cells migrate from dLNs to blood
and preferentially migrate to skin [30]. Effector memory cells do not migrate from blood to dLNs, as they lack
lymph node homing molecules, but express skin homing chemokine receptors, such as CCR4 and CCR10 [31,32].
We do not include effector cells in the homeostasis model, as they are terminally differentiated cells with a short
lifespan [2, 3].
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Figure 1: Mathematical model of CD8+ T cell homeostasis. We consider non-specific (grey) and specific (blue)
naive (Nr and N), central memory (C) (green) and effector memory (M) (brown) CD8
+ T cells. Each cell type
can be in three different spatial compartments: draining LNs (dLNs), blood and resting LNs (B) or skin (S).
Each cell type can divide with rates θn, θc and θm, or die with rates µn, µc and µm, respectively. Non-specific
and specific naive CD8+ T cells populate the peripheral blood (B) compartment from the thymus with rates
δr and Nc δ, respectively. Naive and CM cells migrate between dLNs and B, with rates γ and φ, respectively.
EM cells migrate from dLNs to B with rate ζ, as well as between B and S, with rates ξ and ψ, respectively.
The rates have been labelled with subscripts n, c, and m for naive, central memory, and effector memory cells,
respectively.
2.1.2 Mathematical model of T cell differentiation: decreasing potential model
During antigen challenge, antigen presenting cells (APCs) migrate to the dLNs for efficient antigen presentation
to naive T cells. With the general observation that upon activation by APCs, antigen-specific naive cells give
rise to long-lived memory cells and effector cells, several potential mechanisms have been suggested for T cell
diversification [20, 33]. Experimental studies involving the adoptive transfer and in vivo fate mapping of single
CD8+ T cells [12], chromatin state transitions [34], and metabolism shift during cell differentiation [35], support
a model of progressive differentiation [5,36]. This model of differentiation is also supported by recent studies of
human T cell compartmentalisation [6, 7].
According to this progressive differentiation model, sustained antigenic stimulation of T cells drives differ-
entiation towards effector function. Thus, from naive T cells, central memory cells are generated, followed by
effector memory and effector cells, with further antigen stimulation at each differentiation stage. This model,
known as the “decreasing potential model” (DPM) [37,38] is supported by experimental observations [2,18,39–42]
(see Figure 2).
We will assume that a single APC contact is required to trigger a programme of multiple rounds of division
(or clonal expansion) before differentiation to the next stage of the differentiation pathway can take place [4]
(see Fig. 2 and Fig. 3). By following cellular divisions using carboxyfluorescein succinimidyl ester (CFSE),
experimental studies have shown in both B cells and T cells, that class switching and differentiation depends on
the number of divisions [18,43–46]. Each division enhances the probability of differentiating to a new identifiable
subtype [47].
The mathematical model of CD8+ T cell dynamics during an immune response under the decreasing potential
hypothesis (see Fig. 4) includes the following cell types 1: specific naive cells (N), intermediate cells in the
1Full details of the mathematical model have been provided in Section 5.1.2 and in this section we only present a brief summary
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Figure 2: CD8+ T cell differentiation model during an immune response: decreasing potential model (DPM).
Differentiation is mediated by the interaction between specific CD8+ T cells with antigen presenting cells (APCs)
and proceeds from naive (N) to central memory (C), to effector memory (M), and finally to fully differentiated
effector (E) cells.
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Figure 3: Division-linked differentiation hypothesis: a number of divisions, g, is required for each CD8+ T cell
differentiation step. For example, differentiation from naive (N) (blue) to central memory (C) (green) subtype
requires gn divisions steps (shown here for gn = 3). Each division step gives rise to two intermediate daughter
cells (I) (light green). The first division step requires interaction with an APC and has rate αn. Each subsequent
division step is part of a programme of gn divisions and has rate λn. The last division step gives rise to central
memory cells.
differentiation pathway between naive and central memory cells (I), central memory cells (C), intermediate
cells in the differentiation pathway between central and effector memory cells (J), effector memory cells (M),
intermediate cells in the differentiation pathway between effector memory and effector cells (K), and effector
cells (E). We assume no bystander activation during an immune response and thus, non-specific CD8+ T cell
are not considered [13].
In what follows, we describe, for each cellular subtype, the processes that are included in the DPM:
• Antigen-induced proliferation is triggered by a contact with a cognate antigen presenting cell (see Figure 2).
This contact starts a programme of division events, characterised by the total number of divisions, g, that
leads to differentiation (see Figure 3). The rate of contact with an antigen presenting cell is denoted by
α and is the inverse of the time to first division. The rate of subsequent divisions is denoted by λ and is
the inverse of the time to subsequent divisions. The rates are denoted by the subscripts n, c, and m for
naive, central memory, and effector memory cells, respectively (see Table 2). The division rate of every
population is assumed to be proportional to its corresponding population size. Antigen presentation can
take place in the dLNs and skin compartment.
• The death rates of naive, central memory and effector memory T cells are the same as in the homeostasis
model. For effector cells, we denote their death rate by µe. Intermediate cell types have identical death
rate to those of their parents, so that the death rate of I, J and K cells is µn, µc, and µm, respectively
(see Table 1). As in the homeostasis model, death terms are proportional to the population size of each
subset.
• Migration rules for naive, central and effector memory T cells are as in the homeostasis model. Effector
cells migrate with the same rules and rates as effector memory cells (see Table 2). Intermediate cells in
of the model.
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Figure 4: Mathematical model of CD8+ T cell dynamics during an immune response. The model considers
naive, central memory, effector memory and effector CD8+ T cells and three spatial compartments. T cell
interaction with a cognate APC triggers a programme of division steps that leads to differentiation (decreasing
potential model): from naive to CM, to EM and to fully differentiated effector T cells. Vertical arrows describe
the differentiation programme (linked to division) set by APC interactions. As described in the model of
homeostasis, N, CM and EM divide (oval arrows) (θn, θc, θm), die (µn, µc, µm) and migrate. Effector cells have
the same migratory behaviour as EM cells. Cell subtype specific rates are labelled by the subscripts n, c, m, and
e for naive, central memory, effector memory, and effector cells, respectively. We assume no bystander activation
during an immune response and thus, non-specific naive CD8+ T cells are described by the homeostasis model.
the dLNs and skin compartment have no migratory capability (see Fig. 4).
As the frequency of precursor naive T cells varies [48, 49] and there may be multiple TCR clonotypes
responding to a given cognate antigen [50], we introduce Nc, the number of different TCR clonotypes that are
taking part in the immune response, as an additional parameter of the model. Together the different TCR
clonotypes constitute the antigen-specific CD8+ naive T cell population. We exclude any non-specific naive
CD8+ T cells in the immune response model and thus, neglect any potential bystander activation [13,51].
2.1.3 Mathematical model of T cell differentiation: increasing potential model
The mathematical model of CD8+ T cell dynamics under the increasing potential hypothesis has been described
in Section 5.1.3, and we only summarise the model in this section.
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The differentiation route in the IPM takes naive T cells cells to effector, followed by effector memory and
central memory, with further antigen stimulation at each differentiation stage (see Fig. 5). The mathematical
model considers naive (antigen-specific and non-specific) T cells, as well as effector, effector memory and central
memory cells in three spatial compartments. The events for any given cell type during an immune response
are, as in the DPM case (see Section 2.1.2): encounter with an APC, which starts a programme of division-
linked differentiation steps (see Fig. 6), death, and migration. Non-specific naive T cells are assumed to behave
according to the homeostasis model [13, 51] (see Section 5.1.1). The IPM is depicted in Fig. 7). As discussed
above, we will assume that Nc different and independent TCR clonotypes are taking part in the immune
response, and that all of them can be described with identical rates of activation, proliferation, death and
migration, as well as thymic export [13,22,52]. In this sense and for the mathematical models considered in this
manuscript, Nc is the parameter that encodes how broad the CD8
+ immune response is, as it quantifies how
many different TCR clonotypes are driven to proliferate and differentiate in response to skin-delivered antigen.
N
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C
Figure 5: CD8+ T cell differentiation model during an immune response: increasing potential model. Differen-
tiation is mediated by the interaction between specific CD8+ T cells with antigen presenting cells (APCs) and
proceeds from naive (N) to effector (E), to effector memory (M), and finally to central memory (C) cells.
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Figure 6: Division-linked differentiation hypothesis: a number of divisions, g, is required for CD8+ T cell
differentiation. For example, differentiation from naive (N) (blue) to effector (E) (red) subtype requires gn
divisions steps (shown here for gn = 3). Each division step gives rise to two intermediate cells (I) (pink).
The first division step requires interaction with an APC and is characterised by the rate αn. Each subsequent
division step is part of a programme of gn divisions and is characterised by the rate λn and the last division
step gives rise to E cells.
2.2 Model parameters and computational algorithm
We have made use of the published literature to obtain parameter estimates for the number of cells, carrying
capacities, division rates, death rates and thymic export rates for the different CD8+ T cell populations con-
sidered in the DPM and IPM. Full details can be found in Section 5.2, and, in this section, we provide a brief
summary of our literature review.
Model parameters can be classified into two different types, according to whether they are fixed (see Table 1)
or included in the Bayesian learning when we carry out model calibration (see Table 2). Fixed parameters include
the carrying capacities, division rates, death rates and thymic export rates. These parameters are assumed to
have known values and are set at the same value for both the DPM and IPM.
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Figure 7: Mathematical model of CD8+ T cell dynamics during an immune response (increasing potential
model). The model considers naive, central memory, effector memory and effector CD8+ T cells and three
spatial compartments. The mathematical model of the dynamics during an immune response is based on
the assumption that a T cell interaction with an APC triggers a programme of division steps that leads to
differentiation (increasing potential model): from naive to E, to EM and to central memory (CM) T cells.
Vertical arrows describe the differentiation programme (linked to division) set by APC interactions. As described
in the model of homeostasis, (antigen-specific and non-specific) N, CM and EM CD8+ T cells divide (oval dashed
arrows) (θn, θc, θm), die (µn, µc, µm) and migrate. Naive cells have the same migratory behaviour as CM cells
and effector cells have the same migratory behaviour as EM cells. Cell subtype specific rates are labelled by the
subscripts n, c, m, and e for naive, central memory, effector memory, and effector cells, respectively. We assume
no bystander activation during an immune response and thus, non-specific naive CD8+ T cells are described by
the homeostasis model.
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Parameter Definition Value
κn Carrying capacity per clonotype of naive cells 1,940 cells
Carrying capacity of specific naive cells Nc × κn
κr Carrying capacity of non-specific naive cells (NR −Nc)× κn
κc Carrying capacity per clonotype of specific central memory cells 87,750 cells
κm Carrying capacity per clonotype of specific effector memory cells 87,750 cells
θn Division rate of naive cells 5.63×10−4 per day
θc Division rate of central memory cells 6.49×10−3 per day
θm Division rate of effector memory cells 6.49×10−3 per day
µn Death rate of naive cells 4.46×10−4 per day
µc Death rate of central memory cells 3.67×10−3 per day
µm Death rate of effector memory cells 3.67×10−3 per day
µe Death rate of effector cells 3.57×10−2 per day
δ Thymic export rate per clonotype 0.12 cells per day
Thymic export rate of specific cells Nc × δ
δr Thymic export rate of non-specific cells (NR −Nc)× δ
Table 1: Summary of parameters that are considered fixed in the mathematical models. Details of parameter
estimation from published literature has been provided in Section 5.2.
The rest of the parameters, which are to be included in the Bayesian analysis, are those related to the
immune response, such as the number of divisions in the differentiation programme (g), the time to first
division (1/α), the time to subsequent divisions (1/λ), the number of specific clonotypes involved in the response
(Nc), the duration of the immune response τE , and all migration rates. These parameters will be part of the
model calibration based upon YFV vaccine data from Ref. [11] (see Figure 3B in Ref. [11]). As described in
Section 5.5, given the prior distributions provided in Table 2, we will obtain posterior distributions for this subset
of parameters given a mathematical model and the data. We use uniform distributions for these parameters
because we could not say anything more about the parameters prior to the analysis and we did not want to bias
the analysis. If we had access to further expertise on the parameters, we could have employed formal expert
knowledge elicitation techniques to refine the prior distributions by incorporating expert judgements on the
parameter values [53,54].
Parameter (unit) Definition Prior distribution (unit)
gn, gc, gm, ge Number of generations gn, gc, gm, ge ∼ U{1, 2, . . . , 11}
αn, αc, αm, αe (per day) Rate of first division
1
αn
, 1αc ,
1
αm
, 1αe ∼ U(0.25, 5.0) (day)
λn, λc, λm, λe (per day) Rate of subsequent divisions
1
λn
, 1λc ,
1
λm
, 1λe ∼ U(0.25, 5.0) (day)
γ (per day) Migration rate from dLN to B for N and CM cells 1γ ∼ U(6.94× 10−4, 10.0) (day)
φ (per day) Migration rate from B to dLN for N and CM cells 1φ ∼ U(6.94× 10−4, 10.0) (day)
ζ (per day) Migration rate from dLN to B for EM and E cells 1ζ ∼ U(6.94× 10−4, 10.0) (day)
ξ (per day) Migration rate from B to S for EM and E cells 1ξ ∼ U(6.94× 10−4, 10.0) (day)
ψ (per day) Migration time from S to B for EM and E cells 1ψ ∼ U(6.94× 10−4, 10.0) (day)
Nc Number of TCR clonotypes Nc ∼ U{1, 2, . . . , Nmaxc }
τE (day) Duration of immune challenge τE ∼ U(5, 60) (day)
σ2 Variance in the error term σ2 ∼ IG(3, 1)
Table 2: Summary of parameters and their prior distributions used in the Bayesian analysis for the calibration
of the DP and IP models. Details of the estimation of these parameters from the literature has been provided
in Section 5.2. We have chosen Nmaxc = 10
5 (see Section 5.2.11).
Once a choice of model parameters has been made, the first step is to provide a solution to the system
of equations of the DPM (12)-(29) for the antigen-specific cells, as well as to find a solution to equations (1)
and (5) for the non-specific naive T cell populations. The second step is to choose initial conditions for all the
cell types in the three spatial compartments. The choice of initial conditions depends on the immune scenario
under consideration and a comprehensive discussion has been provided in Section 5.3.
Finally, given a choice of parameters and initial conditions, the ODEs will be solved using a 4th order
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Runge-Kutta method implemented using Python. Thus, parameters, initial conditions and the numerical solver
implemented in Python constitute the computational algorithm that will be referred to as the simulator of the
mathematical model. For the case of the DPM model, the simulator will numerically integrate the equations
described in Section 5.1.2, and, for the IPM, it will integrate those equations in Section 5.1.3.
2.3 Sensitivity analysis
We used global sensitivity analysis methods [55] to check that the model parameters were having the expected
effects on the various model outputs. To achieve this, we have used probabilistic sensitivity analysis techniques
and produced main effect plots using the methods of Ref. [56]. These main effect plots show the average output
response as we vary each parameter in turn. We have also calculated main effect and total effect indices (that
provide a measure of each parameter’s importance in terms of contribution to output uncertainty) in order to
establish which inputs were important for a given model output. This additional analysis has allowed us to
focus our efforts when assessing input parameter uncertainty (using the methods described in Refs. [56,57]). In
order to run these analyses, we needed to specify plausible ranges for each of the input parameters, and these
are given in Table 2.
In our sensitivity analyses, we found that both models had a level of redundancy in that some parameters
had only a limited effect on model output over the plausible ranges. For the DPM, we found that five of the
model parameters had relatively limited effects on the outputs corresponding to the data we had available to
calibrate the model. Similarly, for the IPM, there were six parameters that had negligible effect when varied.
This means that we could not hope to reduce our uncertainty about these parameters in the light of the data
and that carefully modelling of our prior beliefs was not required. Further details of the sensitivity analyses
have been provided in Section 5.4.
2.4 Yellow fever virus vaccine human data and model calibration
2.4.1 Yellow fever virus vaccine human data
We make use of clinical data from the kinetics of virus-specific CD8+ T cell responses. Healthy volunteers (21-32
years of age) were vaccinated with the yellow fever virus (YFV) vaccine 17D (YF-17D) as described in detail in
Ref. [11]. Volunteers were vaccinated with 0.5 mL of the YF-17D vaccine and virus-specific CD8+ T cells were
selected on days 3, 11, 14, 30 and 90 with tetramer staining (HLA-A2 restricted CD8+ T cells specific for the
NS4B epitope of YFV). We have made use of the fraction of specific CD8+ T cells out of the total CD8+ T cell
population at days 11, 14, 30 and 90 post-vaccination for each volunteer (see Ref. [11], Figure 3B).
2.4.2 Model calibration
In order to calibrate the models in the light of the yellow fever data described in Section 2.4.1, we have employed
a Bayesian methodology similar to the ones described in Refs. [58–60]. The general calibration scheme is as
follows: we start with prior distributions for each input parameter that encode uncertainty about the true
values of the inputs, then we update the prior distributions in the light of the data by giving more weight to the
input parameters that would allow the model to reproduce the data. Prior distributions have been described
in Section 2.2 and detailed in Table 2. Given the updated distributions (called the posterior distributions),
we are able to investigate relationships between the parameters and the type of model behaviours that are
supported. There are two substantial technical challenges to overcome when updating the prior distributions in
the light of data: the first is producing a statistical framework for linking the data to the model outputs (that is,
specifying a likelihood function), and the second is the normalisation of the updated probability distributions.
To circumnavigate these problems, we used an approximate Bayesian computation algorithm that allows us
to use the simulator directly, with minimal formal modelling of the statistical link between the model and
data. The simulator and the ABC algorithm we have employed has been fully described in Section 5.3 and
in Section 5.5, respectively. Again, using a Bayesian framework, we can also compare models (in our case the
DPM and the IPM) by asking which model has the highest posterior probability. The posterior probabilities
in this case are found through a combination of prior beliefs about which model is best, and considerations of
which model the data supports. For the prior probabilities, we opted not to favour one model over the other,
so we set the DPM and the IPM to be equally likely. Relative adjustments to the prior probabilities were
made with respect to how well the data could be reconstructed using each model (DPM or IPM). Again, this
adjustment is achieved by making use of an approximate Bayesian computation algorithm that is presented in
Section 5.5. Specific details concerning parameter uncertainty and our calibration methods have been provided
in Section 5.5.
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3 Results
3.1 Model calibration in the light of the data
3.1.1 Model calibration of the decreasing potential model
Table 3 provides summary statistics of the posterior parameter distributions obtained after model calibration
of the decreasing potential model with human YFV vaccination data for Nmaxc = 10
5 (see Table 3).
Nmaxc 10
5
Parameter 2.5% 50% (median) 97.5%
gn 1 3 10
gc 1 3 11
gm 1 4 11
αn 0.21 0.36 2.48
αc 0.20 0.35 2.20
αm 0.20 0.37 2.48
λn 0.21 0.37 2.59
λc 0.20 0.35 2.42
λm 0.20 0.34 2.46
γ 0.10 0.27 7.87
φ 0.10 0.16 1.30
ζ 0.10 0.19 4.41
ψ 0.10 0.18 2.56
ξ 0.10 0.22 7.47
Nc 3,378.65 46,342.00 97,043.23
τE 8.70 21.56 56.72
σ2 0.17 0.43 1.18
Table 3: Summary statistics of the posterior parameter distributions obtained after model calibration of the
decreasing potential model with human YFV vaccination data for Nmaxc = 10
5. For all parameters, median
values and 95% credible intervals (CI) are shown.
Given the data, we learn the most about the following parameters of the decreasing potential model:
• the number of generations for the three cell types (naive, central memory and effector memory): the data
suggest that the number of generations for each cell type, (gn, gc, gm), is likely to be below six in agreement
with a previous mathematical study of the same data, that estimated that the observed expansion of the
CD8+ T cell response was achieved in fewer than nine divisions [8],
• the uncertainty in the migration rates γ and φ has been reduced a little in that higher values of γ and
lower values of φ are supported by the data, and
• the duration of the immune challenge: τE is distributed around 20 days with only a 5% chance of τE < 10
days.
The posterior distributions of gn, gc, gm, 1/γ, 1/φ and τE are given in Figure 8.
In the posterior distributions, we find a strong relationship between gm and τE . It is clear from the posterior
distribution that, if gm is equal to or greater than seven, then τE is generally restricted to being at most 30
days, if we want to be able to reproduce the YFV vaccination data. This can be seen in the scatter plot of the
posterior samples comparing gm and τE (see Figure 9). On the other hand, for lower values of gm, τE can be
any value over seven days and the data can still be reproduced. This effect is having a relatively small impact
on the results, because there is only a 26% chance of gm being equal to or greater than seven from our posterior
distribution.
3.1.2 Model calibration of the increasing potential model
The table below provides a summary statistics of the posterior parameter distributions obtained after model
calibration of the increasing potential model with human YFV vaccination data for Nmaxc = 10
5 (see Table 4).
Given the data, we learn the most about the following parameters of the increasing potential model:
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Figure 8: Bar charts and histograms of posterior samples (dark grey) plotted alongside prior samples (light
grey) for six input parameters of the DPM (gn, gc, gm, 1/γ, 1/φ, τE).
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Figure 9: Scatter plot of posterior samples for input parameters gm and τE in the DPM.
• the model supports lower values of gn and ge,
• the rate of subsequent divisions per day for effector memory cells, λm, is likely to be relatively low (that
is, less than 0.5 per day), and, for the rate of subsequent divisions per day for naive cells, λn, values of
0.35 are favoured by the data, and
• the duration of the immune challenge: τE is distributed around 14 days with only 16% of τE > 20 days.
Overall, the IPM is more readily able to match the data when Nc is smaller than for the DPM case. The
posterior samples for six parameters of the IPM are given in Figure 10.
3.1.3 Model comparison
We have considered two plausible models of T cell responses: a decreasing and an increasing potential model.
In a similar fashion to the way we have established plausible parameter values given the data, we can learn
12
Nmaxc 10
5
Parameter 2.5% 50% (median) 97.5%
gn 1 5 11
ge 1 5 11
gm 1 6 11
gc 1 6 11
αn 0.20 0.37 2.92
αe 0.20 0.34 2.50
αm 0.21 0.36 2.68
αc 0.20 0.37 2.58
λn 0.21 0.36 2.39
λe 0.20 0.33 2.429
λm 0.20 0.38 2.17
λc 0.20 0.38 2.55
γ 0.10 0.21 5.89
φ 0.10 0.18 2.06
ζ 0.10 0.20 5.48
ψ 0.10 0.22 6.80
ξ 0.10 0.19 2.65
Nc 948.73 43,208.00 97,006.47
τE 7.71 15.01 43.16
σ2 0.2 0.46 1.15
Table 4: Summary statistics of the posterior parameter distributions obtained after model calibration of the
increasing potential model with human YFV vaccination data for Nmaxc = 10
5. For all parameters, median
values and 95% credible intervals (CI) are shown.
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Figure 10: Bar charts and histograms of posterior samples (dark grey) plotted alongside prior samples (light
grey) for six input parameters of the IPM (gn, ge, 1/λn, 1/λm, Nc, τE).
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which model is more likely given the data. We do this by setting the prior probability of each model to 50% and
using an extended version of the ABC approach to update that probability in the light of the data. In short, we
randomly choose between the two models before randomly drawing from the distributions for the corresponding
input parameters. When we have a big enough posterior sample, we can count the number of times that each
model was accepted. If one model is more likely than the other, then there will not be an equal number of
acceptances for each model.
We use this approach to compare the decreasing potential model with the increasing potential model. We
find that we need 6.55 × 105 runs to find 2 × 103 acceptable parameter sets for the IPM, whereas we require
just 2.01× 105 runs to find 2× 103 acceptable parameter sets for the DPM. If we assume that, a priori, the two
models are equally likely, then an estimate for the posterior probability of the DPM over the IPM is given by
the following ratio:
2000
2.01×105
2000
2.01×105 +
2000
6.55×105
=
6.55
6.55 + 2.01
= 0.76 ,
which leads to a posterior probability of 0.24 for the IPM because we are only considering two possible models.
Therefore, there is some evidence to suggest that the DPM is the more appropriate model given the YFV
vaccination data, but this is far from being conclusive: we note that these probabilities hinge on the fact that
we are only considering two possible models and both models have been found to be plausible. The same
approach could be used to evaluate a range of plausible models, and the present comparison is an illustration
of the technique.
Here, because we have not explicitly calculated the model likelihoods, traditional information-criteria-based
approaches to evaluating relative model performance are not open to us. However, our comparison approach
based upon posterior probabilities automatically accounts for uncertainty in the model parameters and penalises
for model complexity like many other information-based criteria, such as Akaike information criterion (AIC)
and Bayesian information criterion (BIC).
3.1.4 Division of labour
Our results are in line with the concept of “division of labour” [13,19]. That is, as the naive precursor frequency
increases, and thus, a larger number of antigen-specific naive CD8+ T cells are recruited into the immune
response, fewer divisions are required in the differentiation programme of antigen-specific cells, and greater
timescales for the first division are still enough to mount a timely immune response. We can provide a more
accurate quantification of the previous statement. If we let g = gn+gc+gm and N
max
c = 10
5, we have estimated
the following conditional probabilities:
P(g ≥ 9|Nc < 104) = 0.88 , with (0.82, 0.95) 99% CI ,
P(g ≥ 9|Nc ≥ 104) = 0.69 , with (0.65, 0.72) 99% CI ,
P(g ≥ 10|Nc < 104) = 0.79 , with (0.70, 0.88) 99% CI ,
P(g ≥ 10|Nc ≥ 104) = 0.59 , with (0.56, 0.63) 99% CI ,
P(g ≥ 11|Nc < 104) = 0.63 , with (0.53, 0.74) 99% CI ,
P(g ≥ 11|Nc ≥ 104) = 0.52 , with (0.49, 0.56) 99% CI .
From these results, it can be seen that there is a division of labour in the sense that, if Nc is relatively large,
the chance of having a large number of total divisions in the differentiation programme is significantly reduced.
We note that all these differences are statistically significant at an approximate 1% level, except for when g is
greater than 10. Finally, for Nmaxc = 10
5 the median total number of generations, g = gn + gc + gm, is 11 (see
Table 3). This value is in line with a recent study to quantify the kinetics of CD8+ specific T cells during YFV
vaccination [8] despite the fact that this model did not consider the individual kinetics of each CD8+ specific
T cell subset (N, CM, EM, E).
3.1.5 Initial conditions for antigen-specific naive CD8+ T cells in the decreasing potential model
We have also made use of model calibration to study the posterior distribution of the initial conditions for
antigen-specific naive CD8+ T cells in the decreasing potential model. We have considered that in the case of
YFV vaccination, the initial conditions correspond to a primary immune response (see Section 5.3), so that,
at the time of the challenge (or initial time, t = 0), the only CD8+ T cells present are naive (non-specific and
antigen-specific) and there are no specific central memory, effector memory or effector T cells in any spatial
compartment. A further assumption is the fact that, as described in detail in Section 5.3, prior to the immune
challenge (YFV vaccination), naive cells are assumed to be in homeostatic (or steady-state) conditions (see
Section 5.1.1). This means that N0 and N
(B)
0 , the initial conditions for the antigen-specific naive cell populations
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in the draining lymph nodes and in the blood compartments, respectively, are the stable steady-state solutions
of (2) and (6). It is clear from these equations, that the stable steady-state solutions depend on the fixed
parameters θn, κn, µn and δ, as well as on the Bayesian parameters Nc, γ, φ. The posterior distributions of N0
and N
(B)
0 are shown in Fig. 11. We can derive the following probabilities from these distributions:
P(N0 ≤ 105) = 0.004 , P(N (B)0 ≤ 105) = 0.0015 ,
P(105 < N0 ≤ 106) = 0.0375 , P(105 < N (B)0 ≤ 106) = 0.017 ,
P(106 < N0 ≤ 107) = 0.301 , P(106 < N (B)0 ≤ 107) = 0.1635 ,
P(107 < N0 ≤ 108) = 0.6575 , P(107 < N (B)0 ≤ 108) = 0.818 ,
P(108 < N0) = 0 , P(108 < N (B)0 ) = 0 .
For both N0 and N
(B)
0 , there is the highest probability that the size is in the interval [10
7, 108] with probabilities
of 0.66 and 0.82 for the dLN and blood, respectively.
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Figure 11: Histograms of samples for N0 (left) and N
(B)
0 (right) based on the posterior distributions for the
DPM.
3.2 Model performance in the light of the data
In this section, we make use of the results derived from the model calibration in the light of the YFV data to
study the temporal dynamics of the different CD8+ T cell populations for both the DPM and IPM models.
We have made use of the mathematical models, the fixed parameters (see Table 1), as well as the summary
statistics for each of the models (see Table 3 and Table 4, respectively), and the simulator to generate a time
course that corresponds to the YFV vaccine data, assuming that vaccination takes place at time t = 0.
Fig. 12 shows the median time courses for the fraction of specific CD8+ T cells and the fractions of the four
identified subtypes in blood. For the DPM model, there is a drop in the fraction of naive CD8+ T cells to close
to zero 12 days after the vaccination whereas the fractions of central and effector memory cells peak around
that time. Fig. 13 shows that the IPM exhibits similar behaviour for the naive CD8+ T cells, but the fractions
of central and effector memory cells do not have the same peak.
Because the models are currently calibrated on the specific fraction of CD8+ T cells (out of total CD8+
T cells) alone, there is a great deal of uncertainty shown in the plotted possible time courses (especially for the
four subtypes). Incorporating reliable phenotype data into the analysis would help to reduce this uncertainty
and would benefit the model comparison. Data on the CD8+ T cell fractions around days 15 and 20 after
vaccination would help to further differentiate between the models, since we know from the plausible time
courses that this is where the two models have appreciably different behaviour. The collection of such data is
viable (see Figure 4B of Ref. [11]); however, for the present analysis, the data on the post-vaccination dynamics
of the CD8+ T cell phenotypes were not made available.
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Figure 12: Time course of specific CD8+ T cell subsets in blood generated with the simulator of the decreasing
potential model. Solid lines have been obtained with the median of the posterior parameters and dotted lines
with the 95% credible interval (see Table 3). Top left: fraction of specific naive CD8+ T cells out of total specific
CD8+ T cells. Top right: fraction of specific central memory CD8+ T cells out of total specific CD8+ T cells.
Bottom left: fraction of specific effector memory CD8+ T cells out of total specific CD8+ T cells. Bottom right:
fraction of specific effector CD8+ T cells out of total specific CD8+ T cells. Lower plot: fraction of specific total
CD8+ T cells out of total CD8+ T cells.
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Figure 13: Time course of specific CD8+ T cell subsets in blood generated with the simulator of the increasing
potential model. Solid lines have been obtained with the median of the posterior parameters and dotted lines
with the 95% credible interval (see Table 3). Top left: fraction of specific naive CD8+ T cells out of total specific
CD8+ T cells. Top right: fraction of specific central memory CD8+ T cells out of total specific CD8+ T cells.
Bottom left: fraction of specific effector memory CD8+ T cells out of total specific CD8+ T cells. Bottom right:
fraction of specific effector CD8+ T cells out of total specific CD8+ T cells. Lower plot: fraction of specific total
CD8+ T cells out of total CD8+ T cells.
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4 Discussion
A population-average mathematical model of CD8+ T cell dynamics has been developed that allows us to study
the cellular processes (proliferation, differentiation, migration and death) that regulate the generation of a
diverse and heterogeneous CD8+ T cell population during an immune response. The model considers four cellular
populations, (naive, central memory, effector memory and effector T cells) and three spatial compartments
(draining lymph nodes, circulation and skin). Cell death, division, thymic export, migration, as well as T cell
activation by antigen, and a programme of differentiation-linked division are used to functionally characterise
each CD8+ T cell subtype [16, 17]. Our mathematical models are calibrated with the fraction of total specific
CD8+ T cells from the YFV vaccine data in Ref. [11].
We first consider a differentiation programme based on the “decreasing potential” hypothesis as described
recently in Ref. [12]. These authors carried out single-cell kinetic experiments of murine bacterial infection and
concluded that cells differentiate towards phenotypes with higher proliferation capacity and lower differentiating
capacity [12]. The reverse differentiation scenario, called the linear differentiation model or “increasing potential
model” [20, 33, 61], where effector cells appear earlier than any other phenotype (N→E→EM→CM) has also
been considered in our analysis.
We have made use of the literature to obtain rates of division, death and thymic export for each population
subset. Approximate Bayesian computation (ABC) has been used together with the mathematical model and
YFV vaccination data from Ref. [11] (see Figure 3B in Ref. [11]) to obtain posterior distributions for the subset
of parameters related to the immune response, such as the number of divisions in the differentiation programme,
the time to first division, the time to subsequent divisions, the number of specific clonotypes involved in the
response, the duration of the immune response and migration rates.
After model calibration of the DPM (see Table 3), the median value of g = gn+gc+gm is 11, which is in line
with recent mathematical modelling results that make use of the YFV vaccination data [8,19] and predicted nine
cell divisions for the observed CD8+ T cell expansion. We also find that as the number of naive cells driven to
an immune response increases, there is a reduction in the number of divisions, g, required to differentiate from a
naive to an effector CD8+ T cell, which supports the “division of labour” already observed in mice studies [13].
Our estimates that median division rates, αn, αc, αm, λn, λc, λm, are less than 0.5 per day also agree with the
results of Ref. [8], which predicted a doubling time of two days. As discussed in Ref. [62], and supported by our
results, we note that memory T cells (CM and EM), once generated, are present at higher numbers than naive
cells (see Fig. 12). Their long-term maintenance is guaranteed by homeostatic mechanisms. Our homeostasis
mathematical model encodes this immunological fact by the choice of parameters (reviewed from the literature)
(values of κc > κn and θc > θn).
Model calibration was also carried out for the IPM (see Table 4), as well as model comparison between the
DPM and the IPM. Using a Bayesian approach, we have shown that we can use the data to update parameter
distributions and perform model comparisons. Despite the data being on the number of specific CD8+ T cells, we
are able to make inferences about the model parameters governing differentiation across the different phenotypes.
For the model comparison, our analysis leads to a posterior probability of the IPM equal to 0.24, so the DPM is
favoured by the data, but we cannot rule out either hypothesis. The type of comparison carried out here could
be easily extended to cover multiple models [63], and the associated uncertainty analyses can be used to help
identify where further data could help to aid the model discrimination (as shown in Section 3.2).
The model presented here is relatively comprehensive (see some recent mathematical modelling efforts of
CD8+ T cell responses [8, 14]), yet it fails to include the role of TCR specificity or that of cytokines. Thus,
improvement of the current model will require the consideration of the “signal strength” hypothesis [64] and
cross-reactivity [65]. This will be essential to decipher the role of individual T cell clonotypes, with different
TCR affinities, in the dynamics of a human immune response. Avenues to explore in the future include the
roles of heterogeneity and stochastic behaviour at the single cell level. We have limited ourselves to describing
the mean behaviour of the cell populations. We have also restricted our study to CD8+ T cells.
We have made use of a deterministic model, yet the expression of differentiation, or “binary”, markers by
T cells appears to be stochastic as not all possible phenotypes can be found in the population of T cells that
is generated during an immune response [1]. We still do not have a full understanding of the mechanisms that
regulate cellular fate decision [20]. It is out of the scope of this paper, but our future effort will require the
development of stochastic mathematical models that can account for the inherent randomness at the single cell
level during immune cell differentiation [46].
The inclusion of a skin compartment in our model is partly motivated by a desire to study the dynamics of
the CD8+ T cell response in humans, where the antigen has been delivered via the dermal route, such as in skin
sensitisation [66]. The analysis and the results presented suggest that the Bayesian methodology reported will
enable us to infer model parameters related to the T cell dynamics [67] and TCR repertoire [68] associated with
immune responses via the dermal route. The ability to conclusively distinguish between different hypotheses
(and therefore models) of CD8+ T cell differentiation will depend critically on the availability of phenotype
data from such responses.
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5 Methods
5.1 Mathematical models of CD8+ T cell dynamics
5.1.1 Mathematical model of CD8+ T cell homeostasis
We first introduce the mathematical model that describes the dynamics of CD8+ T cells during homeostasis.
In homeostasis, we consider the following CD8+ T cell subsets: non-specific naive T cells (Nr), antigen-specific
naive T cells (N), antigen-specific central memory T cells (C), and antigen-specific effector memory T cells
(M). We assume that terminally differentiated (antigen-specific) effector T cells (E) do not divide and thus,
are not included in the analysis that follows. We hypothesise that the number of different T cell clonotypes
that are antigen-specific out of the total TCR diversity, NR, and driven into the immune response is Nc. In this
way, N represents the total number of antigen-specific naive T cells that belong to Nc different clonotypes, C
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represents the total number of antigen-specific central memory T cells that belong to Nc different clonotypes,
and M represents the total number of antigen-specific effector memory T cells that belong to Nc different
clonotypes. Finally, we assume that all clonotypes (non-specific and antigen-specific) can be described with
the same parameters for proliferation, death and migration, and thus, are identical [22, 52]. In this sense and
for the mathematical model considered in this manuscript, Nc is the parameter that encodes how broad the
CD8+ immune response is, as it quantifies how many different TCR clonotypes are driven to proliferate and
differentiate in response to the specific antigen.
The mathematical model considers CD8+ T cells in three different spatial compartments: draining lymph
nodes (dLNs), blood and resting lymph nodes (B) and skin (S). CD8+ T cell populations in blood and resting
lymph nodes are labelled with a superscript (B) and those in skin with a superscript (S). The CD8+ T cell
population of the draining lymph nodes is not labelled with a superscript. We include the following processes
in the homeostasis model (see Figure 1):
• Thymic output: naive T cells that have survived thymic selection are incorporated into the peripheral
blood compartment, (B). We denote by δ the thymic export rate per T cell clonotype and by δr the total
thymic non-specific export rate. We note that Nc δ is the total specific naive cell thymic exit rate, and
δr = (NR −Nc) δ is the total non-specific naive cell thymic exit rate.
• Division: we model cell division with a logistic term, with θ the division rate and κ, the carrying capacity
of the population. The logistic term is a simple and standard way to model the competition for limited
resources of a population with a characteristic equilibrium size of κ [22]. We assume that antigen-specific
and non-specific naive cells homeostatically proliferate with the same rate, but have a different carrying
capacity, κr and κn, respectively. Each T cell population divides with rate θn, θc and θm for naive, CM
and EM, respectively, and has corresponding carrying capacities given by κr, κn, κc and κm.
• Cell death: we assume a constant per cell rate of death and we denote it by µ. We assume that specific
and non-specific naive cells die with the same rate. Each cell type can die with rates µn, µc and µm for
naive, CM and EM, respectively.
• Cell migration: we assume that naive and central memory cells migrate between the dLNs and the
resting LNs and blood, but do not migrate to the skin. γ is their migration rate from the dLNs to the
resting LNs and blood, and φ is their migration rate from the resting LNs and blood to the dLNs. We
assume that specific and non-specific naive cells have the same migration rates. Effector memory cells can
only migrate from the dLNs to the resting LNs and blood with rate ζ. They also migrate between the
resting LNs and blood and skin with rates ξ and ψ, respectively.
The ordinary differential equations (ODEs) that describe the homeostasis model are presented below and a
description of the model is provided in Figure 1. Each proliferation and death rate is labelled with a subscript
that corresponds to the population subset under consideration, n, c, and m for naive (N), central memory (CM),
and effector memory (EM) cells, respectively. In the dLNs, we write
dNr
dt
= θn Nr
(
1− Nr
κr
)
− µn Nr − γ Nr + φ N (B)r , (1)
dN
dt
= θn N
(
1− N
Nc κn
)
− µn N − γ N + φ N (B) , (2)
dC
dt
= θc C
(
1− C
Nc κc
)
− µc C − γ C + φ C(B) , (3)
dM
dt
= θm M
(
1− M
Nc κm
)
− µm M − ζ M . (4)
In blood and the resting LNs, we have
dN
(B)
r
dt
= θn N
(B)
r
(
1− N
(B)
r
κr
)
− µn N (B)r − φ N (B)r + γ Nr + δr , (5)
dN (B)
dt
= θn N
(B)
(
1− N
(B)
Nc κn
)
− µn N (B) − φ N (B) + γ N +Nc δ , (6)
dC(B)
dt
= θc C
(B)
(
1− C
(B)
Nc κc
)
− µc C(B) − φ C(B) + γ C , (7)
dM (B)
dt
= θm M
(B)
(
1− M
(B)
Nc κm
)
− µm M (B) − ξ M (B) + ζ M + ψ M (S) . (8)
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Finally, in the skin we have
dM (S)
dt
= θm M
(S)
(
1− M
(S)
Nc κm
)
− µm M (S) − ψ M (S) + ξ M (B) . (9)
In order to solve the previous set of ODEs, we need to provide initial conditions for the nine different cell types
considered in the homeostasis model. We introduce the following notation for the initial conditions of naive
T cells:
Nr(0) = Nr0, N(0) = N0, N
(B)
r (0) = N
(B)
r0 , N
(B)(0) = N
(B)
0 , (10)
and for central and effector memory T cells:
C(0) = C0, M(0) = M0, C
(B)(0) = C
(B)
0 , M
(B)(0) = M
(B)
0 , M
(S)(0) = M
(S)
0 . (11)
Initial conditions will be considered and specified in Section 5.3, where we discuss the computational algorithm
used to solve the ODEs of the combined CD8+ homeostasis, discussed in this section, and immune response
model [69] (either the decreasing potential model, which is described in Section 5.1.2, or the increasing potential
model, which is introduced in Section 5.1.3).
5.1.2 CD8+ T cell dynamics during an immune response: decreasing potential model
We now introduce the mathematical model that describes the dynamics of a CD8+ T cell immune response. We
assume that Nc different TCR clonotypes are driven into the response and thus, the non-specific clonotypes,
NR − Nc, and their naive cells will follow the dynamics that were considered in the homeostasis model, and
given by (1) and (5) (see Section 5.1.1). We also assume, as described above, that the different clonotypes
driven into the response can be described with identical rates, and are thus indistinguishable.
We consider the following CD8+ T cell subsets: antigen-specific naive T cells (N), antigen-specific central
memory T cells (C), antigen-specific effector memory T cells (M), and antigen-specific effector T cells (E). These
different T cell subtypes describe, in a combined way, the Nc clonotypes driven into the immune response. In
this way, N represents the total number of antigen-specific naive T cells that belong to Nc different clonotypes,
C the total number of antigen-specific central memory T cells that belong to Nc different clonotypes, M the
total number of antigen-specific effector memory T cells that belong to Nc different clonotypes, and E the total
number of antigen-specific effector T cells that belong to Nc different clonotypes. The model considers CD8
+
T cells in three different spatial compartments and we follow the notation introduced in Section 5.1.1. Thus, all
T cell populations in blood and resting lymph nodes are labelled with a superscript (B), those in skin with a
superscript (S), and the CD8+ T cell population of the draining lymph nodes is not labelled with a superscript.
We include the following processes in the immune response model (see Figure 4):
• Antigen-driven proliferation and differentiation in the dLNs: we assume that a T cell contact with
an APC starts a programme of division-linked-differentiation for antigen-specific CD8+ T cells, according
to the decreasing potential model (DPM) (see Figure 2). Each differentiation step requires an APC contact
and involves a number of divisions (or generations), g, that depends on the subtype of the T cell, whether
N, CM or EM (see Figure 3). That is, in the dLNs and upon antigen stimulation (APC-mediated), specific
naive cells divide for gn generations to differentiate to central memory cells at the g
th
n division. Similarly,
central memory and effector memory cells divide for gc and gm generations to differentiate to effector
memory and effector cells, respectively, at the last division. We assume that effector memory cells can
also encounter APCs in the S spatial compartment, and differentiate to effector cells. We denote by I,
J , and K the precursor (or intermediate) cells for C, M , and E, respectively (see Figure 3). In this way,
the progeny of N is denoted by I1, the progeny of I1 by I2, the progeny of Ign−1 by C, the progeny of C
by J1, the progeny of J1 by J2, the progeny of Igc−1 by M , the progeny of M by K1, the progeny of K1
by K2, and finally, the progeny of Igm−1 by E. The first division takes place with rate α and subsequent
divisions occur at rate λ. Each of these rates will include a subscript n, c,m depending on the T cell
subtype under consideration, whether N, CM or EM.
• Thymic output: naive T cells are exported from the thymus to the peripheral blood compartment, B,
as described in Section 5.1.1.
• Division: we consider homeostatic proliferation only for N (antigen-specific and non-specific), CM and
EM T cells, as described in Section 5.1.1. We neglect division for the populations I, J and K, as they are
intermediate cells generated during the immune response.
• Cell death: we assume a constant per cell rate of death and we denote it by µ. Each cell type can die
with rates µn, µc, µm, and µe, respectively. We assume that the intermediate populations I, J and K
have the same death rates as their parent subtypes, N, CM and EM, respectively.
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• Cell migration: naive and CM T cells have the same migratory behaviour as described in Section 5.1.1.
EM and effector T cells have the same migratory behaviour, as described for EM T cells in Section 5.1.1.
We assume that the intermediate populations I, J and K do not migrate, thus, they only need to be
considered in the dLN compartment.
The ordinary differential equations (ODEs) that describe the immune response according to the decreasing
potential model are presented below and a description of the model is provided in Figure 4. Each proliferation,
differentiation and death rate is labelled with a subscript that corresponds to the population subset under
consideration, n, c, m and e for naive, central memory, effector memory, and effector cells, respectively. In the
dLNs, we can write
dN
dt
= θn N
(
1− N
Nc κn
)
− αn N − µn N − γ N + φ N (B) , (12)
dI1
dt
= 2 αn N − λn I1 − µn I1 , (13)
dIi
dt
= 2 λn Ii−1 − λn Ii − µn Ii , ∀i = 2, . . . , gn − 1 , (14)
dC
dt
= 2 λn Ign−1 + θc C
(
1− C
Nc κc
)
− αc C − µc C − γ C + φ C(B) , (15)
dJ1
dt
= 2 αc C − λc J1 − µc J1 , (16)
dJi
dt
= 2 λc Ji−1 − λc Ji − µc Ji , ∀i = 2, . . . , gc − 1 , (17)
dM
dt
= 2 λc Jgc−1 + θm M
(
1− M
Nc κm
)
− αm M − µm M − ζ M . (18)
dK1
dt
= 2 αm M − λm K1 − µm K1 , (19)
dKi
dt
= 2 λm Ki−1 − λm Ki − µm Ki , ∀i = 2, . . . , gm − 1 , (20)
dE
dt
= 2 λm Kgm−1 − µe E − ζ E . (21)
In blood and resting LNs, we have
dN (B)
dt
= θn N
(B)
(
1− N
(B)
Nc κn
)
− µn N (B) − φ N (B) + γ N +Nc δ , (22)
dC(B)
dt
= θc C
(B)
(
1− C
(B)
Nc κc
)
− µc C(B) − φ C(B) + γ C , (23)
dM (B)
dt
= θm M
(B)
(
1− M
(B)
Nc κm
)
− µm M (B) − ξ M (B) + ζ M + ψ M (S) , (24)
dE(B)
dt
= −µe E(B) − ξ E(B) + ζ E + ψ E(S) . (25)
Finally, in the skin we have
dM (S)
dt
= θm M
(S)
(
1− M
(S)
Nc κm
)
− αm M (S) − µm M (S) − ψ M (S) + ξ M (B) , (26)
dK
(S)
1
dt
= 2 αm M
(S) − λm K(S)1 − µm K(S)1 , (27)
dK
(S)
i
dt
= 2 λm K
(S)
i−1 − λm K(S)i − µm K(S)i , ∀i = 2, . . . , gm − 1 , (28)
dE(S)
dt
= 2 λm K
(S)
gm−1 − µe E(S) − ψ E(S) + ξ E(B) . (29)
We note that during an immune response, the dynamics for the non-specific CD8+ naive T cells, Nr and
N
(B)
r are regulated by division and given by by (1) and (5) (see Section 5.1.1).
The mathematical model allows us to follow in time and to quantify the number of total specific CD8+
T cells generated during an immune response in each spatial compartment. That is, at any time t ≥ 0, these
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populations are given by
T8(t) = N(t) +
gn−1∑
i=1
Ii(t) + C(t) +
gc−1∑
i=1
Ji(t) +M(t) +
gm−1∑
i=1
Ki(t) + E(t) , (30)
T
(B)
8 (t) = N
(B)(t) + C(B)(t) +M (B)(t) + E(B)(t) , (31)
T
(S)
8 (t) = M
(S)(t) +
gm−1∑
i=1
K
(S)
i (t) + E
(S)(t) , (32)
where T8(t) is the total number of specific CD8
+ T cells in the dLN compartment, T
(B)
8 (t) is the total number of
specific CD8+ T cells in the blood compartment, and T
(S)
8 (t) is the total number of specific CD8
+ T cells in the
skin compartment at time t. We also need to account for the non-specific naive T cell population and thus, the
total number of CD8+ T cells in each spatial compartment at time t, is given by T8(t)+Nr(t), T
(B)
8 (t)+N
(B)
r (t)
and T
(S)
8 (t), respectively. From cell counts, as defined above, the mathematical model also allows us to calculate
the fraction of specific CD8+ T cells out of the total CD8+ T cell population, and the fraction of specific CD8+
T cells of a given subtype (N, CM, EM, E). We define the specific fraction of CD8+ T cells out of the total
CD8+ T cell population in blood, and the fraction of specific CD8+ naive, central memory, effector memory
and effector T cells at a given time t in the blood compartment, as follows
f8(t) =
T
(B)
8 (t)
N
(B)
r (t) + T
(B)
8 (t)
, fn(t) =
N (B)(t)
T
(B)
8 (t)
, fc(t) =
C(B)(t)
T
(B)
8 (t)
, fm(t) =
M (B)(t)
T
(B)
8 (t)
, fe(t) =
E(B)(t)
T
(B)
8 (t)
. (33)
In order to solve the previous set of ODEs, we need to provide initial conditions for the different cell types
considered in the immune response model. We assume that at the initial time there are no intermediate cells,
that is
Ii(0) = 0 , ∀i = 1, . . . , gn − 1 , (34)
Ji(0) = 0 , ∀i = 1, . . . , gc − 1 , (35)
Ki(0) = 0 , ∀i = 1, . . . , gm − 1 , (36)
K
(S)
i (0) = 0 , ∀i = 1, . . . , gm − 1 . (37)
For a primary immune response, we assume that at the initial time there are no specific central memory, effector
memory or effector T cells in any spatial compartment, that is
C(0) = C0 = 0, M(0) = M0 = 0, E(0) = E0 = 0 , (38)
C(B)(0) = C
(B)
0 = 0, M
(B)(0) = M
(B)
0 = 0, E
(B)(0) = E
(B)
0 = 0 , (39)
M (S)(0) = M
(S)
0 = 0, E
(S)(0) = E
(S)
0 = 0 . (40)
In the case of a secondary immune response, the initial conditions for the specific memory subsets (CM or EM),
C0,M0, C
(B)
0 ,M
(B)
0 and M
(S)
0 will be taken to be the number of cells that have been generated during a primary
immune response and maintained by homeostasis in each of the spatial compartments. Initial conditions for
effector cells will be zero, that is, E
(B)
0 = E
(S)
0 = 0. Initial conditions for naive T cells (non-specific and
antigen-specific) will be considered and specified in Section 5.3, where we discuss the computational algorithm
used to solve the ODEs of the combined CD8+ T cell homeostasis and immune response model.
5.1.3 Mathematical model of CD8+ T cell dynamics: increasing potential model
We now introduce the mathematical model that describes the dynamics of a CD8+ T cell immune response under
the hypothesis of increasing potential differentiation (IPM). We assume that Nc different TCR clonotypes are
driven into the response and thus, the dynamics of the non-specific naive T cells is described by the homeostasis
model (see Section 5.1.1). We also assume that the different clonotypes driven into the response can be described
with identical rates, and are thus indistinguishable.
We consider the same CD8+ T cell subsets as in the DPM: antigen-specific naive T cells (N), antigen-specific
central memory T cells (C), antigen-specific effector memory T cells (M), and antigen-specific effector T cells
(E). These different T cell subtypes describe, in a combined way, the Nc clonotypes driven into the immune
response. The model considers CD8+ T cells in three different spatial compartments and we follow the notation
introduced in Section 5.1.1. Thus, all T cell populations in blood and resting lymph nodes are labelled with a
superscript (B), those in skin with a superscript (S), and the CD8+ T cell population of the draining lymph
nodes is not labelled with a superscript. We include the following processes in the immune response model (see
Figure 7):
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• Antigen-driven proliferation and differentiation in the dLNs: we assume that a T cell contact with
an APC starts a programme of division-linked-differentiation for antigen-specific CD8+ T cells, according
to the increasing potential model (see Figure 5). Each differentiation step requires an APC contact and
involves a number of divisions (or generations), g, that depends on the subtype of the T cell, whether N,
E, or EM (see Figure 6). That is, in the dLNs upon antigen stimulation (APC-mediated), specific naive
cells divide for gn generations to differentiate to effector cells at the g
th
n division. Similarly, effector and
effector memory cells divide for ge and gm generations to differentiate to effector memory and central
memory cells, respectively at the last division. We denote by I, J , and K the precursors for E, M , and
C, respectively (see Figure 6). We assume that effector cells can also encounter APCs in the S spatial
compartment, which differentiate to effector memory cells. In this way, the progeny of N is denoted by
I1, the progeny of I1 by I2, the progeny of Ign−1 by E, the progeny of E by J1, the progeny of J1 by J2,
the progeny of Igc−1 by M , the progeny of M by K1, the progeny of K1 by K2, and finally, the progeny of
Igm−1 by C. The first division takes place with rate α and subsequent divisions occur at rate λ. Each of
these rates will include a subscript n, e,m depending on the T cell subtype under consideration, whether
N, E or EM. In the case of central memory cells in the dLNs, we assume that a contact with an APC
starts a programme of gc divisions with no further differentiation events. That is, each proliferation event
gives rise to two central memory cells that are identical to the dividing (or mother) cell. The rate of first
division is αc and subsequent divisions take place with rate λc (see Figure 7). In a similar way and in the S
compartment, a contact between an APC and an effector memory cell starts a programme of gm divisions
with no further differentiation events. That is, each proliferation event gives rise to two effector memory
cells that are identical to the dividing (or mother) cell. The rate of first division is αm and subsequent
divisions take place with rate λm (see Figure 7).
• Thymic output: naive T cells are exported from the thymus to the peripheral blood compartment, B,
as described in Section 5.1.1.
• Division: we consider homeostatic proliferation only for N, CM and EM T cells, as described in Sec-
tion 5.1.1. We neglect homeostatic proliferation for the populations I, J and K, as they are intermediate
cells generated during the immune response.
• Cell death: we assume a constant per cell rate of death and we denote it by µ. Each cell type can die
with rates µn, µc, µm, and µe, respectively. We assume that the intermediate populations I, J and K
have the same death rates as their parent subtypes, N, E and EM, respectively.
• Cell migration: naive and CM T cells have the same migratory behaviour and described in Section 5.1.1.
EM and effector T cells have the same migratory behaviour, as described for EM T cells in Section 5.1.1.
We assume that the intermediate populations I, J and K do not migrate, thus, they only need to be
considered in the dLN compartment.
The ordinary differential equations (ODEs) that describe the immune response for the increasing potential
model are presented below and a description of the model is provided in Figure 7. Each proliferation, differenti-
ation and death rate is labelled with a subscript that corresponds to the population subset under consideration,
n, c, m and e for naive, central memory, effector memory, and effector cells, respectively. In the dLNs, we can
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write
dN
dt
= θn N
(
1− N
Nc κn
)
− αn N − µn N − γ N + φ N (B) , (41)
dI1
dt
= 2 αn N − λn I1 − µn I1 , (42)
dIi
dt
= 2 λn Ii−1 − λn Ii − µn Ii , ∀i = 2, . . . , gn − 1 , (43)
dE
dt
= 2 λn Ign−1 − αe E − µe E − ζ E , (44)
dJ1
dt
= 2 αe E − λe J1 − µe J1 , (45)
dJi
dt
= 2 λe Ji−1 − λe Ji − µe Ji , ∀i = 2, . . . , ge − 1 , (46)
dM
dt
= 2 λe Jge−1 + θm M
(
1− M
Nc κm
)
− αm M − µm M − ζ M . (47)
dK1
dt
= 2 αm M − λm K1 − µm K1 , (48)
dKi
dt
= 2 λm Ki−1 − λm Ki − µm Ki , ∀i = 2, . . . , gm − 1 , (49)
dC0
dt
= 2 λm Kgm−1 + θc C0
(
1− C
Nc κc
)
− αc C0 − µc C0 − γ C0 + φ C(B)0 , (50)
dC1
dt
= 2 αc C0 + θc C1
(
1− C
Nc κc
)
− λc C1 − µc C1 − γ C1 + φ C(B)1 , (51)
dCi
dt
= 2 λc Ci−1 + θc Ci
(
1− C
Nc κc
)
− λc Ci − µc Ci − γ Ci + φ C(B)i , ∀i = 2, . . . , gc − 1 , (52)
dCgc
dt
= 2 λc Cgc−1 + θc Cgc
(
1− C
Nc κc
)
− µc Cgc − γ Cgc + φ C(B)gc , (53)
where the population of central memory cells in the draining lymph nodes is given by C =
∑gc
i=0 Ci.
In blood and resting LNs, we have
dN (B)
dt
= θn N
(B)
(
1− N
(B)
Nc κn
)
− µn N (B) − φ N (B) + γ N +Nc δ , (54)
dE(B)
dt
= −µe E(B) − ξ E(B) + ζ E + ψ E(S) , (55)
dM
(B)
0
dt
= θm M
(B)
0
(
1− M
(B)
Nc κm
)
− µm M (B)0 − ξ M (B)0 + ζ M + ψ M (S)0 , (56)
dM
(B)
j
dt
= θm M
(B)
j
(
1− M
(B)
Nc κm
)
− µm M (B)j − ξ M (B)j + ψ M (S)j , ∀j = 1, . . . , gm (57)
dC
(B)
i
dt
= θc C
(B)
i
(
1− C
(B)
Nc κc
)
− µc C(B)i − φ C(B)i + γ Ci , ∀i = 0, . . . , gc , (58)
where the population of effector memory cells in the blood compartment is given by M (B) =
∑gm
i=0M
(B)
i and
the population of central memory cells in the blood compartment is given by C(B) =
∑gc
i=0 C
(B)
i .
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Finally, in the skin we have
dE(S)
dt
= −αe E(S) − µe E(S) − ψ E(S) + ξ E(B) , (59)
dJ
(S)
1
dt
= 2 αe E
(S) − λe J (S)1 − µe J (S)1 , (60)
dJ
(S)
i
dt
= 2 λe J
(S)
i−1 − λe J (S)i − µe J (S)i , ∀i = 2, . . . , ge − 1 , (61)
dM
(S)
0
dt
= 2 λe J
(S)
ge−1 + θm M
(S)
0
(
1− M
(S)
Nc κm
)
− αm M (S)0 − µm M (S)0 − ψ M (S)0 + ξ M (B)0 , (62)
dM
(S)
1
dt
= 2 αm M
(S)
0 + θm M
(S)
1
(
1− M
(S)
Nc κm
)
− λm M (S)1 − µm M (S)1 − ψ M (S)1 + ξ M (B)1 , (63)
dM
(S)
i
dt
= 2 λm M
(S)
i−1 + θm M
(S)
i
(
1− M
(S)
Nc κm
)
− λm M (S)i − µm M (S)i − ψ M (S)i + ξ M (B)i , ∀i = 2, . . . , gm − 1(64)
dM
(S)
gm
dt
= 2 λm M
(S)
gm−1 + θm M
(S)
gm
(
1− M
(S)
Nc κm
)
− µm M (S)gm − ψ M (S)gm + ξ M (B)gm , (65)
where the population of effector memory cells in the skin compartment is given by M (S) =
∑gm
i=0M
(S)
i .
We note that, during an immune response, the dynamics of the non-specific CD8+ naive T cells, Nr and
N
(B)
r is regulated by cell division and given by by (1) and (5) (see Section 5.1.1).
The IP mathematical model allows us to follow in time and to quantify the number of total specific CD8+
T cells generated during an immune response in each spatial compartment. That is, at any time t ≥ 0, these
populations (in the increasing potential model) are given by
T8(t) = N(t) +
gn−1∑
i=1
Ii(t) + E(t) +
ge−1∑
i=1
Ji(t) +M(t) +
gm−1∑
i=1
Ki(t) +
gc∑
i=0
Ci(t) , (66)
T
(B)
8 (t) = N
(B)(t) + E(B)(t) +
gm∑
i=0
M
(B)
i (t) +
gc∑
i=0
C
(B)
i (t) , (67)
T
(S)
8 (t) = E
(S)(t) +
ge−1∑
i=1
J
(S)
i (t) +
gm∑
i=0
M
(S)
i (t) , (68)
where T8(t) is the total number of specific CD8
+ T cells in the dLN compartment, T
(B)
8 (t) is the total number
of specific CD8+ T cells in the blood compartment, and T
(S)
8 (t) is the total number of specific CD8
+ T cells
in the skin compartment. As mentioned in Section 5.1.2, the total number of CD8+ T cells in each spatial
compartment at time t, is given by T8(t) + Nr(t), T
(B)
8 (t) + N
(B)
r (t) and T
(S)
8 (t), respectively. The IPM will
also allows us to calculate the total fraction of specific CD8+ T cells out of the total CD8+ T cell count in
blood and the fraction of specific CD8+ T cells of a given subtype in blood. These fractions have already been
defined in (33). For the increasing potential model, we note that T
(B)
8 (t) is given by (67), N
(B)(t) solves (54),
E(B)(t) solves (55), M (B)(t) is given by
∑gm
i=0 M
(B)
i (t), where M
(B)
0 (t) solves (56) and M
(B)
j (t) solves (57) for
1 ≤ j ≤ gm, and C(B)(t) is given by
∑gc
i=0 C
(B)
i (t), where C
(B)
j (t) solves (58).
In order to solve the previous set of ODEs, we need to provide initial conditions for the different cell types
considered in the IPM immune response model. We assume that at the initial time there are no intermediate
cells, that is
Ii(0) = 0 , ∀ i = 1, . . . , gn − 1 , (69)
Ji(0) = J
(S)
i (0) = 0 , ∀ i = 1, . . . , ge − 1 , (70)
Ki(0) = M
(B)
i (0) = M
(S)
i (0) = 0 , ∀ li = 1, . . . , gm − 1 , (71)
Ci(0) = C
(B)
i (0) = 0 , ∀ i = 1, . . . , gc . (72)
For a primary immune response, and as discussed in Section 5.1.2, we assume that at the initial time there are
no specific central memory, effector memory or effector T cells in any spatial compartment. In the case of a
secondary immune response, as described in Section 5.1.2, there are no effector cells at the initial time. Initial
conditions for the memory subsets (CM or EM), C0,M0, C
(B)
0 ,M
(B)
0 and M
(S)
0 , will be taken to be the number
of cells that have been generated during a primary immune response and maintained by homeostasis in each of
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the spatial compartments [see Section 5.3]. Initial conditions for naive cells (non-specific and antigen-specific)
will be considered and specified in Section 5.3, where we discuss the computational algorithm used to solve the
ODEs of the combined CD8+ T cell homeostasis and immune response model.
5.2 Parameter estimates from published literature
In this Section, we make use of the published literature to obtain parameter estimates for the number of cells,
carrying capacities, division rates, death rates and thymic export rates.
5.2.1 Cell numbers
(i) Naive TCR diversity.
The human naive TCR diversity (or number of different TCR clonotypes) has been estimated to be 2.5×107
in Ref. [70]. We denote this parameter by NR.
(ii) Total number of lymphocytes (in lymph nodes and blood).
The total number of lymphocytes in humans has been estimated to be 4.60 × 1011 from a quantitative
assessment of lymphocyte numbers in mucosal and lymphoid tissues [71]. These authors also report that
the total number of lymphocytes in the lymph nodes is 1.90× 1011 and the total number of lymphocytes
in the blood is 1.0× 1010 (see Table 1 of Ref. [71]).
(iii) Total number of CD8+ T cells (in lymph nodes and blood).
In Ref. [71] the authors make use of the distribution of CD8+ T cells in different organs and tissues
(provided in Ref. [72]), to estimate that the total number of CD8+ T cells in humans is 1.09× 1011. They
are also able to estimate that the total number of CD8+ T cells in the LNs is 3.8 × 1010 and 2.5 × 109
in blood (see Table 3 of Ref. [71]). We also note that making use of the estimates provided in Ref. [73]
(Table 3 and Table S1), the mean number of CD8+ T cells (for five healthy individuals aged between 20
and 25) in 5 litres (L) of blood is 2.59× 109. These authors have assumed that the total blood volume in
humans is 5L and that 2% of all T cells reside in blood [72]. Given these two different estimates for the
total number of CD8+ T cells in blood, we take their average to obtain 2.55× 109.
(iv) Total number of naive CD8+ T cells (in lymph nodes and blood).
Recent experimental observations allow us to calculate the number of naive CD8+ T cells in the lymph
nodes and blood in humans [74]. The frequency of naive CD8+ T cells is found to be 48% in the inguinal
lymph nodes, 39% in the lung lymph nodes and 40% in the mesenteric lymph nodes (see Figure 3B of
Ref. [74]). If we assume that 42.3% of all CD8+ T cells in the LNs are naive (average of the above
percentages), we then obtain that 1.61 × 1010 = 0.423 × 3.8 × 1010 is the number of naive CD8+ T cells
in the LNs. In blood the frequency of naive CD8+ T cells is found to be 39% (see Figure 3B of Ref. [74]),
which implies that 9.95 × 108 = 0.39 × 2.55 × 109 is the number of naive CD8+ T cells in blood. This
last number can be also estimated from Table S1 of Ref. [73] . These authors estimate that 56.6% of all
CD8+ T cells in blood are naive. If there are 2.55×109 CD8+ T cells in blood, we conclude that there are
1.44×109 naive CD8+ T cells in blood. Given these two different estimates for the number of naive CD8+
T cells in blood, we take their average to obtain 1.22 × 109. A recent estimate from Ref. [75] (Table 2)
indicates that the (averaged over young and aged individuals) number of naive CD8+ T cells in blood is
142.5 cells per µL. Thus, these authors conclude that the total number of naive CD8+ T cells in blood
is 7.13× 108. From the two different estimates, 1.22× 109 and 7.13× 108, we assume that their average,
9.7 × 108 is the total number of naive CD8+ T cells in blood for humans. Finally, if we assume, as done
by the authors of Ref. [73], that 2% of all T cells reside in blood [72], we obtain 4.85× 1010 to be the total
number of naive CD8+ T cells in humans. We denote this parameter by N8.
(v) Number of naive CD8+ T cells per clonotype (in lymph nodes and blood).
Given the TCR diversity, NR, we can now estimate the number of naive CD8
+ T cells per clonotype in the
LNs and in blood. For the LNs, we obtain 644 = 1.61×1010/NR and for blood, we have 39 = 9.7×108/NR.
(vi) Number of lymph nodes (LNs) in the human body.
The mathematical models developed in this manuscript consider three different spatial compartments: the
draining lymph nodes (dLNs), the resting lymph nodes and blood (B) and skin (S). Naive cells are found
in the first two compartments, and we need to calculate the number of naive CD8+ T cells per clonotype
in each of these two spatial locations (dLNs and B). Ref. [76] estimates the number of individual LNs in
humans to be 600, as well as Ref. [77]. Ref. [78] estimates this number to be in the range [600, 700], with a
mean of 650. If we take the average of 600 and 650, we obtain 625 to be the the number of individual LNs
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in humans. Our interest in skin sensitisation scenarios (or cutaneous vaccination) leads us to consider the
axilla site to be the dLN compartment [79]. In the axilla site, it is reported that the number of individual
LNs is in the range of [20, 30] [77]. We will consider then that there are 25 individual LNs in the axilla
site, which correspond to the draining LNs. Thus, for our purposes we assume there are 25 dLNs and 600
resting LNs.
(vii) Number of naive CD8+ T cells per clonotype in dLN compartment.
Our previous estimates allow us to conclude that the number of naive CD8+ T cells per clonotype in an
individual LN is 644/625 (number of naive CD8+ T cells per clonotype in LNs divided by the number of
individual LNs in humans). We approximate 644/625 by 1, that is, there is one naive CD8+ T cell per
clonotype in an individual LN. As the dLNs have 25 individual LNs, we conclude that n
(dLN)
c , the number
of naive CD8+ T cells per clonotype in the dLN compartment is 25. Finally, we note that the total number
of naive CD8+ T cells in the dLN compartment is NR × n(dLN)c .
(viii) Number of naive CD8+ T cells per clonotype in B compartment.
We now compute the number of naive CD8+ T cells per clonotype in the blood compartment, which is
composed of the resting lymph nodes and blood. Our previous estimates lead to 600 resting LNs. Thus,
there are 600 naive CD8+ T cells per clonotype in the resting LNs. We had previously obtained 39 naive
CD8+ T cells per clonotype in blood. Together these results imply that the spatial B compartment consists
of 639 naive CD8+ T cells per clonotype. We denote this number by n
(B)
c . If we multiply n
(B)
c by NR, we
obtain the total number of naive CD8+ T cells in the blood compartment.
(ix) Number of specific and non-specific naive CD8+ T cells in dLN and in B compartments.
Let us define Nc to be the number of different TCR clonotypes driven into an immune response. This
implies thatNR−Nc is the number of non-specific TCR clonotypes. As n(dLN)c is the number of naive CD8+
T cells per clonotype in the dLN compartment, this means that Nc × n(dLN)c and (NR − Nc) × n(dLN)c
is the total number of antigen-specific and non-specific, respectively, naive CD8+ T cells in the dLN
compartment. For the B compartment, the previous results generalise to Nc×n(B)c and (NR−Nc)×n(B)c ,
as the total number of specific and non-specific, respectively, naive CD8+ T cells in the B compartment.
5.2.2 Carrying capacities
(i) Carrying capacity per clonotype of the naive CD8+ T cell population.
We first estimate the carrying capacity per clonotype of the naive CD8+ T cell population, κn. We assume
that κn is given by
N8
NR
, as N8 is the total number of naive CD8
+ T cells in humans and NR its TCR
diversity. This means that if there are Nc clones driven into an immune response, the carrying capacity
of the specific naive CD8+ T cell population is Nc × κn.
(ii) Carrying capacity of the non-specific naive CD8+ T cell population.
For the non-specific naive CD8+ T cell population its carrying capacity is denoted by κr and it is given
by (NR −Nc)× κn.
(iii) Carrying capacity per clonotype of the central and effector memory CD8+ T cell population.
We now estimate the carrying capacity per clonotype of the central, κc, and effector, κm memory CD8
+
T cell populations. To this end, we make use of Table 5, that provides measurements of the fraction of
both central and effector memory CD8+ T cell populations in blood. Thus, the number of central and
effector memory CD8+ T cells in blood is given by 4.09 × 108 = 16.02% × 2.55 × 109 and 4.85 × 108 =
19.03% × 2.55 × 109, and the total number of memory CD8+ T cells in blood is 8.94 × 108. A recent
estimate from Ref. [75] (Table 2) indicates that the (averaged over young and aged individuals) number
of memory CD8+ T cells in blood is 101.5 cells per µL. This implies that the total number of memory
CD8+ T cells in blood (assuming 5L of blood in humans) is 5.08×108. We average over these two different
estimates to conclude that there are 7.01 × 108 memory CD8+ T cells in blood. Assuming that 2% of
all T cells reside in blood [72], we obtain 3.51× 1010 to be the total number of memory CD8+ T cells in
humans. In order to obtain the carrying capacity per clonotype, we require an estimate of memory TCR
diversity. Ref. [80] reports that the number of clonotypes observed in the human memory population is
about 2×105 (see Figure 1D of Ref. [80]). A similar diversity was estimated in Ref. [70], 1-2×105 different
β chains, which on average only paired with a single α chain each. If we assume that κc = κm, we conclude
that κc = κm = 87, 750 =
3.51×1010
2×2×105 .
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Reference Markers Measure (%) Naive Central memory Effector memory Effector
Table 2, Ref. [81] CD45RA and CD27 median 44.00 28.00 7.00 7.00
Figure 1, Ref. [82] CD45RA and CD27 mean 31.12 22.05 19.68 30.53
Table 2, Ref. [83] CD45RA and CD27 median 52.00 33.00 3.00 11.50
Figure 1, Ref. [84] CD45RA and CCR7 mean 27.82 6.65 40.06 23.09
Figure 3B, Ref. [74] CD45RA and CCR7 mean 39.00 8.03 23.00 30.19
Table 1, Ref. [85] CD45RA and CCR7 mean 40.40 8.55 18.45 26.80
Table S3, Ref. [6] CD45RA and CCR7 mean 44.55 5.85 22 27.61
average 39.84 16.02 19.03 22.39
Table 5: Reported (percentage) distribution of CD8+ T cell subsets in blood.
5.2.3 Division rates
(i) Total production rate of naive CD8+ T cells. In Ref. [73] (Table 3), the median naive CD8+
T cell production per day is estimated to be 2.39× 107 cells. The authors of Ref. [75] (Table 2) report a
production rate (averaged over young and aged individuals) of 1.55 × 107 cells per day. We consider the
average of these two different estimates to yield 1.97× 107 naive CD8+ T cells per day.
(ii) Thymic rate of naive CD8+ T cells. For a human adult, 20% of the production of naive CD8+ T cells
is contributed from the thymus [86] and the remaining 80% of production is from peripheral proliferation.
In Ref. [87] the authors report that thymic production is 11% of the total. We take the average of these
two estimates, 15.5%, to be the thymic contribution to naive CD8+ T cell production.
(iii) Division rate of naive CD8+ T cells.
The above estimate leads to 84.5% to be the peripheral contribution to naive CD8+ T cell production.
Given the total production rate, 1.97× 107 naive CD8+ T cells per day, this means that 1.66× 107 naive
CD8+ T cells per day are generated by peripheral proliferation. If N8 is the total number of naive CD8
+
T cells, then 3.42×10−4 = 1.66×107N8 per day is the homeostatic naive division rate. The authors of Ref. [88]
estimated that naive T cells divide once every 3.5 years in the periphery, which leads to 7.83 × 10−4 per
day as the homeostatic naive division rate. We take the average of these two different estimates to obtain
θn = 5.63× 10−4 per day.
(iv) Division rate of central and effector memory CD8+ T cells.
In order to estimate θc and θm, the division rate of central and effector memory CD8
+ T cells, respectively,
we make use of the estimated proliferation rates provided in Ref. [88]. The authors estimated that memory
T cells divide once every 22 weeks, which leads to 6.49 × 10−3 per day. We assume θm = θc, since the
authors do not distinguish between CM and EM T cells.
5.2.4 Death rates
(i) Death rate of naive CD8+ T cells.
Our first estimate for the death rate of CD8+ naive T cells, µn, has been obtained making use of Ref. [73]
(Table 2). In this reference, the authors provide the median half-life of naive CD8+ T cells to be 2,374
days. We make use of the fact that the death rate is given by log 2half-life to obtain 2.92 × 10−4 per day.
A second estimate provides an average turnover rate of 0.06% per day (averaged over young and aged
individuals). This is equivalent to a lifespan of 4.5 years for naive CD8+ naive T cells or to a death rate
of 6.09 × 10−4 per day (see Table 2 of Ref. [75]). We take the average of the above estimates to obtain
µn = 4.51× 10−4 per day.
(ii) Death rate of central and effector memory CD8+ T cells.
The authors of Ref. [73] (Table 2) also provide the median half-life of memory CD8+ T cells to be 244 days.
Thus, we estimate 2.84 × 10−3 per day. A second estimate provides an average turnover rate of 0.45%
per day (averaged over young and aged individuals). This is equivalent to a lifespan of approximately 222
days for memory CD8+ T cells or to a death rate of 4.05 × 10−3 per day (see Table 2 of Ref. [75]). We
take the average of the above estimates to obtain µc = 3.67 × 10−3 per day. We assume µm = µc, since
the authors do not distinguish between CM and EM T cells.
(iii) Death rate of effector CD8+ T cells.
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Finally, the death rate of effector CD8+ T cells, µe, has been estimated from the observation that effector
CD8+ T cells have a lifespan of about four weeks [51]. As the death rate = 1lifespan , we obtain µe =
3.57× 10−2 per day.
5.2.5 Thymic export rates
(i) Thymic rate per CD8+ T cell clonotype.
We have estimated above that 15.5% is the thymic contribution to naive CD8+ T cell production and
that the total production rate of naive CD8+ T cells is 1.97 × 107 cells per day. This implies that
0.12 = 15.5%× 1.97× 107/NR is the thymic output per clonotype and per day. We denote this parameter
by δ. If Nc TCR clonotypes are driven into an immune response, the total rate of thymic export for
antigen-specific naive CD8+ T cells is Nc × δ.
(ii) Thymic rate for non-specific CD8+ naive T cells.
Given the estimate for δ above, and that there are NR − Nc non-specific naive CD8+ T cell clonotypes,
the total rate of thymic export for non-specific naive CD8+ T cells is δR = (NR −Nc)× δ.
5.2.6 Migration rates
Recent estimates from mice of the timescales of T cell migration provide a range between 0.5 minutes to 3
days [89]. Naive T cells in mice have been estimated to reside in the lymph nodes for timescales that range
between 0.5 and three days [90]. Finally, the timescale of effector T cells to exit from the lymph nodes have been
estimated to be of the order of minutes to hours (see Figure 2 in Ref. [91]). Given these estimates, we choose
to assume that the timescales of migration in our model, γ−1, φ−1, ζ−1, ψ−1, and ξ−1 are not fixed parameters
and will be sampled from a uniform distribution with minimum one minute and maximum ten days, as shown
in Table 2.
5.2.7 Changes in lymph node influx and efflux
(i) Change in influx rate.
Bovine data indicate that during an initial period of 3.5 days, lymph node influx increases from 4.67× 106
to 15.04 × 106 T cells per hour. This means a 3.22 fold increase during the first 3.5 days post-infection.
This will be implemented in our model as follows: during the first 3.5 days post-infection (post-challenge
or post-vaccination) the migration rate φ will be increased by a factor of 3.22 to become 3.22× φ.
(ii) Change in efflux rate.
The output of lymphocytes in the efferent lymph (from a lymph node draining a PPD-induced delayed type
hypersensitivity reaction in sheep) has been shown to decrease significantly over the first 24 hours [92]. We
have taken the average of the fold-reduction in output observed at 9, 12, 15, 21 and 24 hours, which was
0.26, 0.19, 0.16, 0.23, 0.29, and 0.37 (see Figure 1 in Ref. [92]), to obtain a value of 3.4 fold-reduction during
a period of twenty four hours. A different set of bovine data indicates a three fold-reduction in the efflux
rate at 12 hours post-exposure to orf virus, which reaches resting levels by 24 hours. We take this set of
data to obtain a 3 fold-reduction during a period of twenty four hours. The average of these two estimates
leads to a 3.2 fold-reduction in efflux during a period of twenty four hours. This will be implemented in our
model as follows: during the first 2 days post-infection (post-challenge or post-vaccination) the migration
rates γ (for naive and central memory T cells) and ζ (for effector and effector memory T cells) will be
decreased by a factor of 3.2 to become γ/3.2 or ζ/3.2, respectively.
5.2.8 Programme of proliferation: number of generations
A recent mathematical modelling effort, in combination with human CD8+ YFV kinetic data [11, 93], has
estimated that during the differentiation process CD8+ T cells undergo fewer than nine divisions [8]. Given this
estimate and our division-linked differentiation hypothesis, we choose to assume that the number of divisions,
encoded in the parameters gn, gc, gm and ge, to undergo differentiation are not fixed parameters and will be
sampled from a uniform distribution with minimum one division and maximum eleven divisions (see Table 2).
5.2.9 Time to first division
The time to first division for CD8+ T cells has been measured in the mouse OT-I model [94] and estimated
to be approximately two days, with a range of 29 to 55 hours. In our model the parameter α is the inverse of
the time to first division, and thus, we will assume that the parameters α−1n , α
−1
c , α
−1
m and α
−1
e for each CD8
+
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T cell subtype (N, CM, EM or E), are not fixed parameters and will be sampled from a uniform distribution
with minimum 0.25 days and maximum 5 days (see Table 2).
5.2.10 Time to subsequent divisions
In Ref. [12], the authors have made use of experimental data from the OT-I transgenic mouse model, with
CD8+ T cells that are specific for the SIINFEKL peptide from chicken ovalbumin (OVA), and mathematical
modelling to estimate the doubling time of these cells. Their estimates range between 0.8 and 1.64 days (see
Figure S17 in Ref. [12]). The estimate for the doubling time of CD8+ T cells provided by the authors of Ref. [8]
is 1.8 days. These authors have also made use of a mathematical model, in combination with human CD8+
YFV kinetic data [11,93], to derive this estimate from the range 1.4 to 2.66 days for the doubling time of human
CD8+ T cells. In our model the parameter λ is the inverse of the time to subsequent divisions (or doubling
time), and thus, we will assume that the parameters λ−1n , λ
−1
c , λ
−1
m and λ
−1
e for each CD8
+ T cell subtype (N,
CM, EM or E), are not fixed parameters and will be sampled from a uniform distribution with minimum 0.25
days and maximum 5 days (see Table 2).
5.2.11 Maximum number of clonotypes recruited to the immune response
Recent human CD4+ estimates of the number of clonotypes recruited to the immune response range between
100 and 5,000 (see Figure 1 in Ref. [95]). CD8+ mice data from viral infections show that more than 1,000
clonotypes have responded to a given immuno-dominant epitope, with a range between 102 to 105 (see the
Abstract in Ref. [50]). Given these estimates, we choose to assume that the number of clonotypes recruited to
the immune response, Nc, will not be a fixed parameter and will be sampled from a uniform distribution with
minimum one and maximum Nmaxc = 10
5, given the above estimates (see Table 2).
5.2.12 Duration of immune challenge
The data used to carry out model calibration indicate that viral titers become undetectable by day 16 post-
vaccination [11]. Yet, the fraction of specific CD8+ T cells increases until day 30 post-vaccination and declines
by day 90 post-vaccination (see Figure 3 in Ref. [11]). Given these estimates, we choose to assume that the
the duration of the immune challenge, τE , will not be a fixed parameter and will be sampled from a uniform
distribution with minimum 5 days and maximum 60 days (see Table 2).
5.3 Computational algorithm
Solving the ODEs that describe the dynamics of antigen-specific and non-specific CD8+ T cells during an
immune response (according to the DPM hypothesis), requires finding a solution to the set of equations (12)-
(29) for the antigen-specific cells, as well as finding a solution to equations (1) and (5), for the non-specific
naive T cell populations. In order to do so, the first thing that we require is to choose a set of parameters, as
described in Section 2.2 and Section 5.1.2. We note that a subset of parameters are fixed, and given in Table 1,
and the rest of the parameters will be sampled from a number of distributions, as described in Table 1. Once
a set of parameters has been chosen, and before we can solve the system of ODEs at hand, the next step is to
choose initial conditions for all the cell types in the three spatial compartments. The choice of initial conditions
depends on the immune scenario under consideration. For a primary immune response, we will assume that at
the initial time (t = 0), the only CD8+ T cells present are naive (non-specific and antigen-specific) and thus,
there are no specific central memory, effector memory or effector T cells in any spatial compartment, that is
C0 = M0 = E0 = C
(B)
0 = M
(B)
0 = E
(B)
0 = M
(S)
0 = E
(S)
0 = 0. Naive cells are assumed to be in homeostatic
(or steady-state) conditions prior to the immune challenge. This means that Nr0, N0, N
(B)
r0 and N
(B)
0 , the
initial conditions for the naive cell populations in the draining lymph nodes and in the blood compartments,
respectively, are the stable steady-state solutions of equations (1), (2), (5) and (6). If we consider the limit in
which the migration terms tend to zero in these equations (without loss of generality, but in order to simplify
the expressions), the steady-state solutions, labelled with a star, are given by
N?r =
κr
θn
(θn − µn) , (73)
N? =
Nc κn
θn
(θn − µn) , (74)
N (B)?r =
1
2 θn
[
κr (θn − µn) +
√
κ2r (θn − µn)2 + 4 κr δr θn
]
, (75)
N (B)? =
1
2 θn
[
Nc κn (θn − µn) +
√
N2c κ
2
n (θn − µn)2 + 4 N2c κn δ θn
]
. (76)
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Given a choice of parameter values, we set Nr0 = N
?
r , N0 = N
?, N
(B)
r0 = N
(B)?
r , N
(B)
0 = N
(B)?, as these steady-
state solutions can be shown (in the limit in which the migration terms tend to zero) to be the unique stable
steady-state solutions of the system of equations given by (1), (2), (5) and (6). In fact, it is easy to prove that
in this limit, the eigenvalue of the Jacobian matrix is given by µn − θn, which is negative for the parameters
described in Table 1.
For a secondary immune response, we will assume that at the initial time (t = 0), the only CD8+ T cells
present are naive (non-specific and antigen-specific), central memory and effector memory cells, but no effector
cells in any spatial compartment. N, CM and EM CD8+ T cells are assumed to be in homeostatic (or steady-
state) conditions prior to a secondary immune challenge. This means that the initial conditions for these
populations in the draining lymph nodes, in the blood and in the skin compartments, are the stable steady-
state solutions of the equations described in Section 5.1.1 for the DPM. If we consider the limit in which
the migration terms tend to zero in these equations (without loss of generality, but in order to simplify the
expressions), the steady-state solutions for these populations, labelled with a star, are given by
N?r =
κr
θn
(θn − µn) , (77)
N? =
Nc κn
θn
(θn − µn) , (78)
C? =
Nc κc
θc
(θc − µc) , (79)
M? = 0 , (80)
N (B)?r =
1
2 θn
[
κr (θn − µn) +
√
κ2r (θn − µn)2 + 4 κr δr θn
]
, (81)
N (B)? =
1
2 θn
[
Nc κn (θn − µn) +
√
N2c κ
2
n (θn − µn)2 + 4 N2c κn δ θn
]
, (82)
C(B)? =
Nc κc
θc
(θc − µc) , (83)
M (B)? =
Nc κm
θm
(θm − µm) , (84)
M (S)? =
Nc κm
θm
(θm − µm) . (85)
The previous expressions are for reference only, as we have solved the equations in their full generality with
migration terms included. If migration terms are included, the analytical expressions of the steady-states
become more complicated, and thus, have not been included. Yet, we have been able to show that for our
choice of parameters, the equations of the homeostasis model for the naive, central and effector memory T cell
populations described in Section 5.1.1, have a unique stable steady-state that reduces to the solution presented
above, if migratory terms are neglected.
Finally, given a choice of parameters and initial conditions, the ODEs were solved using a 4th order Runge-
Kutta method implemented using Python. Thus, parameters, initial conditions and the numerical solver im-
plemented in Python constitute the computational algorithm that will be referred to as the simulator of the
mathematical model. For the case of the DPM model, the simulator will numerically integrate the equations
described in Section 5.1.2, and for the IPM, it will integrate the equations presented in Section 5.1.3. The initial
conditions for the IPM are chosen in a similar way as done for the DPM, and the details are not included here.
5.4 Sensitivity analysis for the decreasing potential model
When implementing a mathematical model within some computational algorithm (or simulator), it is important
to verify that the resulting simulator is behaving in the way that is meant. It can also be beneficial to identify the
inputs to that simulator that have an impact on the simulator outputs: if we can identify such important inputs,
we can determine which inputs need to be determined more carefully and which inputs we have the best chance of
learning about in a parameter estimation scheme. For the present simulator (described in Section 5.3), we have
performed a global sensitivity analysis as described in Ref. [55]. In this analysis, we propagate the uncertainty
in the inputs (as discussed earlier) through the simulator to obtain uncertain outputs. The uncertainty in the
outputs can be apportioned to each input, in terms of their direct and indirect impacts, and the underlying
principle is that the inputs that are responsible for causing the most uncertainty in the outputs are the most
important.
The direct (that is, the input acting alone) and indirect (that is, the input acting in conjunction with other
inputs) effects that inputs have on an output can be quantified using main and total effect indices [57]. The
main effect index for an input gives the proportion of variance in the output that is directly accounted for by
that input alone. The total effect index for an input gives the proportion of variance in the output that is
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accounted for by that input alone and through interactions that input has with other inputs. As such, it is
not typical for the main effect indices or the total effect indices to sum to one when considering the indices
for all inputs, because the main effect indices only account for inputs acting alone and the total effect indices
double count interaction effects. In addition to these indices, we are able to visualise the main effect of an input
through a plot of the expected value of the output conditional on fixed values of that input.
Of course, for our simulator, we do not have a single output: we have multiple time series. For our sensitivity
analysis, we focus on the model outputs that relate to the data that we will use to calibrate the model. In our
case, model outputs are f8(t), fn(t), fc(t), fm(t) and fe(t) for t = 11, 14, 30, 90 days post-vaccine. This gives us
twenty potential outputs to consider (we, in fact, consider the logit transformed outputs). We have calculated
main effect indices and total effect indices considering each of the outputs in turn. To get an overall picture
of the importance of the inputs across all outputs simultaneously, we have employed a principal component
analysis (PCA) on the outputs and calculated the indices for the first four principal components (which account
for approximately 90% of the variability in the sampled outputs).
Using the main and total effect indices from the analysis of the first four principal components, we find that
the most important parameters are (in order of importance): τE , λc, gn, gc, gm, λn, λm, φ and γ. Although
these parameters have an impact across all of the outputs, it is difficult to interpret the estimated main effects
because the corresponding principal components are not on the same scale as the simulator’s outputs.
We can therefore investigate the role of the most important parameters by considering their impact on
individual inputs. Figure 14 is a plot of τE against the conditional expectation of log
[
T
(B)
8 (t = 30)
]
, where
this expectation is calculated by fixing the value of τE and finding the average value of log
[
T
(B)
8 (t = 30)
]
with
respect to the uncertainty in the other input parameters. For all of the input parameters, we consider their
influence on the model outputs over the ranges specified in Table 2. We can see that as τE increases, the total
number of CD8+ antigen-specific T cells at 30 days increases until τE = 30 days, when the number of cells
stabilises.
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Figure 14: Plot of the conditional expectation of log[T
(B)
8 (t = 30)] given fixed values of τE for the DPM where
we average over the uncertainty in the remaining model parameters.
Other parameters, such as the number of generations for the different subtypes, have a much more mundane
effect, where the total number of antigen-specific cells increases as gn, gc and gm increase. For λc, as this
parameter increases, the total number of antigen-specific cells also increases. The same effect is observed for
λn, λm and φ, whereas an opposite (but weaker effect) is seen for γ (as shown in Figure 15).
We also note that we may be able to rule out lower values of Nc when we learn the parameters from data
(see Section 3.1). This is because Nc has an impact on the model outputs for low values alone. Essentially,
the total number of CD8+ T cells is reduced for relatively small values of Nc, and this effect disappears for
Nc & 25, 000, where the outputs are seemingly unaffected by Nc.
In addition to performing sensitivity analyses on the outputs that correspond to observed data, we can
consider the influence of the input parameters on other model outputs, such as the maximum number of antigen-
specific CD8+ T cells in blood and the time at which this maximum is realised. For the output maxt[T
(B)
8 (t)],
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Figure 15: Plot of the conditional expectation of log[T
(B)
8 (t = 30)] given fixed values of four different input
parameters in the DPM (1/λn, 1/λc, 1/φ and 1/γ).
we found that τE and the number of generations had a leading role, alongside αm and φ. In fact, in order of
relevance, the parameters that influence the output maxt[T
(B)
8 (t)] are τE , gc, gn, gm and αm. It is clear from
Figure 16 that, as the number of generations and τE increase, maxt[T
(B)
8 (t)] increases.
For the time at which maxt[T
(B)
8 (t)] is realised, the most influential parameter by far is τE (the total effect
of τE accounts for 85% of the variance in the time to the maximum). As expected, as τE increases, the time
taken to reach the maximum increases (see Figure 17). For completeness, we also include a histogram for the
time taken to reach the maximum in the DPM for Nmaxc = 10
5 (see Figure 18)
5.4.1 Sensitivity analysis for the increasing potential model: a brief comment
For completeness, we conducted the same probabilistic sensitivity analysis for the increasing potential model
(both for individual outputs and for PCA transformed outputs). Four parameters are more influential than any
others in that they regularly have relatively high total effect indices for all the outputs of interest: τE , gn, λn
and ge. As in the case of the decreasing potential model, τE has a great impact on the number of antigen-specific
cells in the blood compartment. There are several other input parameters that cause some of the variance for
some of the outputs: gc, αc, λe, λm, φ and ξ.
5.5 Calibration method
We take a Bayesian approach to the calibration of the simulator’s input parameters: we set prior distributions
for each of the parameters and update them in the light of the data and the mathematical model. The updated
distributions are called posterior distributions. Given the complexity of the model and the approximate nature
of the likelihood, we employ an approximate Bayesian computation (ABC) approach [96]. For such an approach,
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Figure 16: Plot of the conditional expectation for the maximum number of antigen-specific CD8+ T cells in
blood given fixed values of four different input parameters in the DPM (gn, gc, gm and τE fixed one-at-a-time
and averaging over the uncertainty in the remaining 15 parameters).
we do not need to specify a likelihood function for the data given the simulator: we just need to be able to
simulate data in a similar form to the data that we have. The basic ABC approach that we employ is as follows:
0. Decide on the number of required samples N , and set i = 0.
1. Make a single draw from the prior distributions of the unknown input parameters.
2. Run the simulator in order to use the drawn input parameters to find a set of outputs that correspond to
the data.
3. If the simulated data are sufficiently close to the observed data, add the drawn input parameters to your
sample and increase i by one.
4. If i < N , go to step 1.
In step 2, and to simulate data, we can run the simulator for any given set of input values to get a set
of outputs that correspond to the data that we will observe. If we make the judgement that the simulator
is providing outputs that correspond to the CD8+ specific T cell fraction f8(t) for the average human post-
vaccination, then we need to also specify a mechanism that can generate the variability in the human population.
For the specific T cell fraction at time t, f8(t), we use a log normal distribution with its mean provided by the
simulator and a variance to be learnt from the data. These choices result in a need to learn the input parameters
and the variability parameter value from the data. Given the data, plausible distributions are as follows:
log
(
f
8,obs(t)
)
|Θ, σ2 ∼ N
(
f
8,model(t), σ
2
)
for t ∈ {11, 14, 30, 90},
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Figure 17: Plot of the conditional expectation for the time taken (in days) to reach the maximum number of
antigen-specific CD8+ T cells in blood, maxt[T
(B)
8 (t)], given fixed values of τE in the DPM.
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Figure 18: Histogram of the time taken to reach the maximum number of antigen-specific CD8+ T cells in
blood, maxt[T
(B)
8 (t)], based upon the posterior distributions of the DPM input parameters.
where Θ is the complete set of input parameters and σ2 is the variance in the observed data.
In step 3, we compare the simulated data with the observed data. Here we must choose what distance
measure to use and what tolerance is permitted. Both of these choices have an impact on the accuracy on the
approximation. For instance, if we consider a Euclidean distance between the simulated and observed data sets
and set the tolerance to be zero, then the algorithm provides an exact posterior result. In our case, because the
data are continuous, there is zero chance of replicating the data exactly so we must have a non-zero tolerance
and the size of the tolerance will determine the length of time it takes for the algorithm to produce the sample.
We calculate the Euclidean distance between log
[
f8,obs(t)
]
and log
[
f
8,model(t)
]
for each of the time points
and for each of the individuals and compare this with tolerance T . The final value of T we used was 13.5
for both the DPM and IPM models. Using the same value for the tolerance was important because the ABC
results were used in the model comparison of Section 3.1.3.
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